<SEC-DOCUMENT>0001193125-13-429318.txt : 20131106
<SEC-HEADER>0001193125-13-429318.hdr.sgml : 20131106
<ACCEPTANCE-DATETIME>20131106103701
ACCESSION NUMBER:		0001193125-13-429318
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20131105
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131106
DATE AS OF CHANGE:		20131106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		131195108

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d623654d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): November&nbsp;5, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-19961</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: 011-59-99-465-8525 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02. <U>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers</U>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;5, 2013, James F. Gero, Chairman of the Board of
Directors (the &#147;<U>Board</U>&#148;) of Orthofix International N.V. (the &#147;<U>Company</U>&#148;), retired as Chairman and a director. Also on November&nbsp;5, 2013, the Board appointed Randy Thurman and Kathleen Regan to the Board, and
appointed Mr.&nbsp;Thurman as Chairman. The Board has determined that each of Mr.&nbsp;Thurman and Ms.&nbsp;Regan are independent directors under the rules of the Nasdaq Stock Market. There are no transactions involving Mr.&nbsp;Thurman or
Ms.&nbsp;Regan requiring disclosure under Item&nbsp;404(a) of Regulation S-K. As of the date of this filing, no final decisions have been made by the Board with respect to which, if any, of the Board committees Mr.&nbsp;Thurman or Ms.&nbsp;Regan
will serve. Pursuant to the terms of the Company&#146;s articles of association, as amended, the Board has adopted a resolution increasing its size from seven to eight directors in connection with these appointments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has approved, following approval and recommendation by the Compensation Committee of the Board (the &#147;<U>Compensation
Committee</U>), annual cash compensation of $120,000 to Mr.&nbsp;Thurman for his service as Chairman, and the grant of options to acquire 30,000 shares of common stock to each of Mr.&nbsp;Thurman and Ms.&nbsp;Regan pursuant to the Company&#146;s
2012 Long-Term Incentive Plan (vesting in each case in 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> increments on each of the first, second, third and fourth anniversary of his or her appointment pursuant to the Company&#146;s
previously filed form of non-employee director non-qualified stock option agreement). Ms.&nbsp;Regan will receive the Company&#146;s standard fee of $60,000 per year for non-employee director service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with his retirement, Mr.&nbsp;Gero has agreed to remain as a consultant to the Board through January&nbsp;2, 2015, and has
entered into a consulting letter agreement with the Company (the &#147;<U>Consulting Letter Agreement</U>&#148;). Under the Consulting Agreement, the Company will pay Mr.&nbsp;Gero $5,000 per month (with additional amounts owed to the extent he
performs more than eight hours of consulting services at the Company&#146;s request in any month) and reimburse him for the cost of his health care coverage through January&nbsp;2, 2015. The Consulting Letter Agreement was approved by the Board
following recommendation by the Compensation Committee. The foregoing description of the Consulting Letter Agreement does not purport to be complete and is qualified in its entirety by the text of the Consulting Letter Agreement, which is filed
herewith as Exhibit 10.1 and which is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01. <U>Regulation FD Disclosure</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;6, 2013, the Company issued a press release regarding certain of the matters described in Item&nbsp;5.02. That press release
is furnished herewith as Exhibit 99.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information included in this Current Report on Form 8-K under this Item&nbsp;7.01 (including
Exhibit&nbsp;99.1) shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), or otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. <U>Financial Statements and Exhibits</U>. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Consulting Letter Agreement, dated as of November&nbsp;5, 2013, between Orthofix International N.V. and James F. Gero.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Press Release, dated November 6, 2013.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Orthofix International N.V.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jeffrey M. Schumm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey M. Schumm</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Administrative
Officer, General Counsel and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: November&nbsp;6, 2013 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consulting Letter Agreement, dated November 5, 2013, between Orthofix International N.V. and James F. Gero.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated November 6, 2013.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d623654dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g623654g08m58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;5, 2013 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;James&nbsp;F. Gero </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman of the Board of Orthofix
International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3451 Plano Pkwy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Jim: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per our discussions, we understand that you
intend to retire as Chairman of the Board, and as a director, of Orthofix International N.V. (the &#147;<U>Company</U>&#148;), effective as of November&nbsp;5, 2013. As further discussed, we appreciate that you have agreed to provide the Company
with certain transition assistance by acting as a consultant to the Board between November&nbsp;5, 2013 and January&nbsp;2, 2015 (the &#147;<U>Continued Service Period</U>&#148;). This letter agreement between you and the Company serves to
memorialize the terms that you and the Company have agreed regarding your consulting relationship with the Company and certain related matters. Capitalized terms not defined herein shall have the meanings set forth on <U>Exhibit A</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Consulting Arrangement </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the Continued Service
Period, you will make yourself available to provide consulting services to the board of directors of the Company (the &#147;<U>Board</U>&#148;) eight hours per month at such time(s) as mutually agreed by you and the Company, with in each case at
least one week&#146;s notice and subject to your reasonable scheduling availability. Such consulting services shall be provided at such location(s) as mutually agreed by you and the Company (provided that, in any event, you shall not be asked to
travel more than 25 miles from his Texas or Maine residence), and may include providing strategic advice, market analysis, business development, employee mentoring, or other similar activities. You also agree to make yourself available to
participate telephonically, as needed, during portions of up to two meetings of the Board during the Continued Service Period (which appearances shall be counted for purposes of calculating the eight hours of service referenced in the first sentence
of this paragraph). As payment for you providing these services, the Company shall provide you compensation of (i)&nbsp;$5,000 per month during the Continued Service Period (which payment shall be made whether or not the Board avails itself of all
of the services you are agreeing to provide to the Board hereunder) and (ii)&nbsp;$625 per hour for any consulting services you provide at the Company&#146;s request in excess of eight hours in any given month. In addition, provided that you elect
COBRA in a timely manner, the Company will provide you with a monthly cash payment (subject to applicable taxes and less any required withholding) equal to the cost of continuation coverage under the Company&#146;s medical and dental benefit plans
in which you were participating at the time of your retirement as a director, at the level at which you were </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
participating (e.g., single or family coverage). Any COBRA continuation coverage that you elect to continue after January&nbsp;2, 2015 shall be fully at your own expense. You shall perform your
consulting services as an independent contractor, and nothing herein shall create any employment relationship between you and the Company or any of its subsidiaries. Jeffrey M. Schumm, the Company&#146;s Chief Administrative Officer and General
Counsel, shall be your point of contact and liason for scheduling, arranging and providing the consulting services described above and for any other matters related to any transitional or ongoing administrative matters between you and the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your vesting and exercise periods with respect to your options to acquire common stock of the Company (&#147;<U>Stock Options</U>&#148;) and grants of
restricted common stock of the Company (&#147;<U>Restricted Stock</U>&#148;) shall be as set forth in the applicable grant agreement and/or plan, provided, however, that for the avoidance of doubt, the parties hereto agree that you shall be deemed
to be a &#147;Service Provider&#148; under the Company&#146;s 2012 Long-Term Incentive Plan (and therefore continue to vest in restricted stock grants made to you thereunder) for so long during the Continued Service Period as you are continuing to
provide consulting services to the Board hereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Standstill </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You agree that from and after the date of this letter agreement through January&nbsp;2, 2015 (the &#147;<U>Protective Period</U>&#148;), unless the prior
written consent of the Board has been obtained, neither you nor any entities of which you are the majority equity owner will in any manner, directly or indirectly, (a)&nbsp;effect, seek, offer, or propose (whether publicly or otherwise), or cause or
participate in (except to sell or tender your Company securities in the ordinary course pursuant to any consummated public sale of the Company) or in any way assist any other person to effect, seek, offer, or propose (whether publicly or otherwise)
(i)&nbsp;any acquisition of beneficial ownership of any securities issued by the Company or any assets of the Company or any of the Company&#146;s direct or indirect subsidiaries (other than (A)&nbsp;pursuant to the exercise of your existing Stock
Options or (B)&nbsp;acquisitions not to exceed in the aggregate more than one percent (1%)&nbsp;of the outstanding shares of Company common stock (excluding Company common stock already beneficially owned by you or entities of which you are the
majority equity owner as of the date hereof or exercisable by you pursuant to Stock Options)); (ii)&nbsp;any tender or exchange offer, merger, or other business combination involving the Company; (iii)&nbsp;any recapitalization, restructuring,
liquidation, dissolution, or other extraordinary transaction with respect to the Company or any of its subsidiaries; or (iv)&nbsp;any &#147;solicitation&#148; of &#147;proxies&#148; (as those terms are used in the proxy rules of the Securities and
Exchange Commission) to vote, or refrain from voting, any voting securities issued by the Company or to solicit any consents of the Company&#146;s shareholders; (b)&nbsp;form, join, or in any way participate in a &#147;group&#148; (as defined under
the Securities Exchange Act of 1934) with respect to any securities issued by the Company or otherwise act, alone or in concert with others, to seek to control or influence (except through providing consulting services hereunder) the Company&#146;s
management, the Board, or the Company&#146;s policies; (c)&nbsp;take any action which might require the Company or any of its subsidiaries to make a public announcement regarding any of the types of matters set forth in (a)&nbsp;or (b)&nbsp;above;
or (d)&nbsp;enter into any discussions or arrangements with any third party with respect to any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Non-Competition; Non-Solicitation and Confidentiality </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You also agree that during the Protective Period you shall not, without the prior written consent of the Board (which may be withheld in the Board&#146;s sole
and absolute discretion), anywhere in the Prohibited Area, for your own account or the benefit of any other, engage or participate in or assist or otherwise be connected with a Competing Business. For the avoidance of doubt, you understand that this
paragraph prohibits you from acting for yourself or as an officer, employee, manager, operator, principal, owner, partner, shareholder, advisor, consultant of, or lender to, any individual or other Person that is engaged or participates in or
carries out a Competing Business or is actively planning or preparing to enter into a Competing Business. The parties agree that such prohibition shall not apply to your passive ownership of not more than 5% of a publicly-traded company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, during the Protective Period you shall not, without the prior written consent of the Board (which may be withheld in the Board&#146;s sole
discretion),&nbsp;whether for your own account or for the account or benefit of any other Person, throughout the Prohibited Area: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">request, induce or attempt to influence (i)&nbsp;any customer of the Company or its subsidiaries to limit, curtail, cancel or terminate any business it transacts with, or products or services it receives from or sells
to, or (ii)&nbsp;any Person employed by (or otherwise engaged in providing services for or on behalf of) the Company or its subsidiaries to limit, curtail, cancel or terminate any employment, consulting or other service arrangement, with the Company
or its subsidiaries. Such prohibition shall expressly extend to any hiring or enticing away (or any attempt to hire or entice away) any employee or consultant of the Company or its subsidiaries. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">solicit from or sell to any customer any products or services that the Company or any of its subsidiaries provides or is capable of providing to such customer and that are the same as or substantially similar to the
products or services that the Company or any of its subsidiaries, sold or provided while you are or were providing services to the Board. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">contact or solicit any customer for the purpose of discussing (i)&nbsp;services or products that are competitive with and the same or closely similar to those offered by the Company or any of its subsidiaries or
(ii)&nbsp;any present business of the Company or any of its subsidiaries. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">request, induce or attempt to influence any supplier, distributor or other Person with which the Company or any of its subsidiaries has a business relationship or to limit, curtail, cancel or terminate any business it
transacts with the Company or any of its subsidiaries. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top">otherwise interfere with the relationship of the Company or any of its subsidiaries with any Person which is, or within the last year was, doing business with, employed by or otherwise engaged in performing services
for, the Company or any of its subsidiaries. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the Protective Period and at all times thereafter, you agree to hold in secrecy for the
Company all Confidential Information that may come into your knowledge, may have come to your attention or may have come into your possession or control while providing services to the Company and/or the Board. Notwithstanding the preceding
sentence, you shall not be required to maintain the confidentiality of any Confidential Information which (a)&nbsp;is or becomes available to the public or others in the industry generally (other than as a result of disclosure or inappropriate use,
or caused, by you in violation of this paragraph) or (b)&nbsp;you are compelled to disclose under any applicable laws, regulations or directives of any government agency, tribunal or authority having
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
jurisdiction in the matter or under subpoena. Except as expressly required in the performance of your duties under this agreement, you agree not to use for your own benefit or disclose (or permit
or cause the disclosure of) to any Person, directly or indirectly, any Confidential Information unless such use or disclosure has been specifically authorized in writing by the Company in advance. During the period during which you are providing
consulting services to the Board hereunder, the Company may provide and grant you access to certain Confidential Information. You recognize that any Confidential Information is of a highly competitive value, will include Confidential Information not
previously provided you and that the Confidential Information could be used to the competitive and financial detriment of the Company or its subsidiaries if misused or disclosed by you. The Company provides access to such Confidential Information
only in exchange for your promises contained herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Statements and Disclosures </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You agree that you have not made and shall not make, publicly or privately, any critical or negative comments to the media or any significant critical or
negative comments to any other Person regarding the Company or any of its subsidiaries, or of their respective directors, officers, employees or agents, provided that the foregoing shall in no way limit your right to make any public statements or
disclosures you believe, after consultation with counsel, are required by applicable law, or required or appropriate pursuant to applicable federal securities laws. The Company further agrees that it shall not make, and shall use commercially
reasonable efforts to prevent any of its respective officers or directors from making, any critical or negative comments to the media or other persons about you, provided that the foregoing shall in no way limit the Company&#146;s right to make any
public statements or disclosures it believes, after consultation with counsel, are required or appropriate under applicable law, or required or appropriate pursuant to applicable federal securities laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Governing Law and Venue </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement shall be
construed, interpreted, and governed in accordance with the laws of the State of Texas without regard to any provision of that state&#146;s rules on the conflicts of law that might make applicable the law of a jurisdiction other than that of the
State of Texas. All actions or proceedings arising out of this agreement shall exclusively be heard and determined in state or federal courts in the City of Dallas of the State of Texas having appropriate jurisdiction. The parties expressly consent
to the exclusive jurisdiction of such courts in any such action or proceeding and waive any objection to venue laid therein or any claim for forum nonconveniens. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Entire Agreement </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement represents the entire
agreement of the parties with respect to the subject matter hereof and shall supersede any and all previous contracts, arrangements or understandings between you and the Company relating to your potentially providing consulting services to the
Company and/or the Board. Nothing in this Agreement shall modify that certain indemnity agreement between you and the Company dated October&nbsp;31, 2008 (the &#147;<U>Indemnity Agreement</U>&#148;) or, except as specifically set forth herein, alter
any of your rights under the Company&#146;s employee benefit plans or related award agreements, or under the Company&#146;s articles of association, as amended (the &#147;<U>Articles</U>&#148;). In furtherance of the foregoing, the Company reaffirms
its obligations to you under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnity Agreement and the Articles, including with respect to indemnification and the advancement and/or reimbursement of reasonable legal expenses in certain circumstances on the terms
provided for therein), and agrees that you shall be deemed to be acting in an &#147;official capacity&#148; as defined thereunder while providing the consulting services contemplated by this Agreement. In the event of any conflict between this
agreement and any other agreement between you and the Company, this agreement shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[remainder of page intentionally left blank]
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please indicate your agreement and acknowledgment to the above by signing where indicated below and returning a
copy to me. Your signature below will also constitute resignation by you, as of the open of business on November&nbsp;5, 2013, from all officer and director positions with the Company or any of its subsidiaries (including as a director of the
Company). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">O<SMALL>RTHOFIX</SMALL> I<SMALL>NTERNATIONAL</SMALL> N.V.</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bradley R. Mason</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Agreed and Accepted:</B></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James F. Gero</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James F. Gero</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;<U>Competing Business</U>&#148;</B>&nbsp;means any business or activity that (i)&nbsp;competes with the Company or any of its
subsidiaries and involves (ii)&nbsp;(A)&nbsp;the same or substantially similar types of products or services (individually or collectively) manufactured, marketed or sold by the Company or any of its subsidiaries as of the date hereof or
(B)&nbsp;products or services so similar in nature to that of the Company or any of its subsidiaries as of the date hereof (or that the Company or any of its subsidiaries will soon thereafter offer and are known to Mr.&nbsp;Gero) that they would be
reasonably likely to displace substantial business opportunities or customers of the Company or any of its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><U>&#147;Confidential Information</U>&#148;</B>&nbsp;shall include Trade Secrets and includes information acquired by you in the course and
scope of your activities under this agreement or from previously serving as Chairman of the Board or a director of the Company, including information acquired from third parties, that (i)&nbsp;is not generally known or disseminated outside the
Company and its subsidiaries (such as non-public information), (ii)&nbsp;is designated or marked by the Company or any of its subsidiaries as &#147;confidential&#148; or reasonably should be considered confidential or proprietary, or (iii)&nbsp;the
Company or any of its subsidiaries indicates through its policies, procedures, or other instructions, in each case to the extent known to Mr.&nbsp;Gero, should not be disclosed to anyone outside the Company and its subsidiaries. Without limiting the
foregoing definitions, some examples of Confidential Information under this agreement include (a)&nbsp;matters of a technical nature, such as scientific, trade or engineering secrets, &#147;know-how&#148;, formulae, secret processes, inventions, and
research and development plans or projects regarding existing and prospective customers and products or services, and (b)&nbsp;information about costs, profits, markets, sales, customer lists, customer needs, customer preferences and customer
purchasing histories, supplier lists, internal financial data, personnel evaluations, non-public information about the Company&#146;s medical devices or products of the Company or any of its subsidiaries (including future plans about them),
information and material provided by third parties in confidence and/or with nondisclosure restrictions, computer access passwords, and internal market studies or surveys. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;<U>Person</U>&#148;</B>&nbsp;shall include individuals or entities such as corporations, partnerships, companies, firms, business
organizations or enterprises, and governmental or quasi-governmental bodies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;<U>Prohibited Area</U>&#148;</B>&nbsp;means North
America, South America and the European Union, which Prohibited Area the parties have agreed to as a result of the fact that those are the geographic areas in which the Company and its subsidiaries conduct a preponderance of their business and in
which you provide substantive services to the benefit of the Company and its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;<U>Trade
Secrets</U>&#148;</B>&nbsp;are information of special value, not generally known to the public that the Company or any of its subsidiaries has taken steps to maintain as secret from Persons other than those selected by the Company or any of its
subsidiaries. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d623654dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g623654g50y22.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix Appoints Two New Independent Board Members </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Randy Thurman Named Chairman; Expands Board to Eight Directors </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LEWISVILLE, Texas &#150; November&nbsp;6, 2013 &#150; Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced the addition of Randy Thurman
and Kathleen (&#147;Kathy&#148;) Regan as new independent directors to the Company&#146;s Board, effective immediately. Mr.&nbsp;Thurman succeeds Jim Gero as Chairman of the Board. Mr.&nbsp;Gero, who has served on Orthofix&#146;s Board since 1998
and as Chairman since 2005, has retired from the Board upon the appointment of Mr.&nbsp;Thurman and has agreed to serve as a consultant to the Board until January 2015. With these appointments, the Orthofix Board of Directors is comprised of eight
members, seven of who are independent and all of whom are annually elected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;On behalf of the Board of Directors, the Orthofix management team and
all employees, I want to thank Jim for his many years of service and tireless commitment to Orthofix,&#148; said Brad Mason, President and Chief Executive Officer of Orthofix. &#147;Jim&#146;s leadership and guidance have been integral to Orthofix
and its growth, and we wish him the best in his future endeavors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Gero said, &#147;I am honored to have served on the Orthofix Board for
16 years, the last nine as Chairman. Over the past several months, the Board and I have searched for potential new board candidates, and I&#146;m excited that we&#146;ve found and been able to appoint two outstanding new directors in Randy and
Kathy. With their addition, I feel it&#146;s the right time for me to retire as a director and Chairman, and I look forward to assisting the Board as a consultant.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Randy and Kathy are two exceptional leaders in the healthcare industry and we are delighted to welcome them to our Board of Directors,&#148; said
Mr.&nbsp;Mason. &#147;Over the past few months we have reorganized our business to try to better focus on operational performance and increase the Company&#146;s growth potential. We believe our new directors bring a wide range of industry,
financial and general business experience to Orthofix. We are confident that Randy&#146;s operational, CEO and Chairman experience will help us as we work towards stabilizing and driving our organic business, and that Kathy&#146;s extensive M&amp;A
background will be invaluable to potential future inorganic growth opportunities.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am extremely enthusiastic about joining Orthofix at a
time when I believe it is positioned for significant value creation,&#148; said Mr.&nbsp;Thurman. &#147;Brad has assembled an exceptional leadership team, and I am very impressed by the operational improvements that are being implemented at the
Company. I see this as an inflection point in Orthofix&#146;s future, and I look forward to working with Brad and his team to capitalize on the many opportunities that lie ahead.&#148; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Randy Thurman </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Randy Thurman currently serves as a consulting advisor in private equity and has worked with firms such as New Mountain Capital LLC and AEA Investors LP. Prior
to that, he was a Founder, Chairman&nbsp;&amp; CEO of VIASYS Healthcare Inc., a global leader in respiratory and neurological diagnostics, critical care, medical/surgical technologies and orthopedic product development and manufacturing.
Mr.&nbsp;Thurman was named an Ernst&nbsp;&amp; Young Entrepreneur of the Year in 2007. Prior to joining VIASYS Healthcare Inc., he was Founder and CEO of Strategic Reserves LLC, which provided advisory services to bio-pharmaceutical, genomic and
medical device companies. He also previously served as Executive Chairman of Enzon Inc., a publicly traded biopharmaceutical company, and as Chairman&nbsp;&amp; CEO of Corning Life Sciences, Inc., Corning Incorporated&#146;s health care division and
the predecessor to Quest Diagnostics Incorporated and Covance Inc. Earlier in his career, Mr.&nbsp;Thurman was with Rorer Pharmaceuticals Inc., where he led its successful acquisition of Revlon Healthcare and subsequent merger with
Rh&ocirc;ne-Poulenc. He subsequently served as President of Rorer Pharmaceuticals Inc. and Rhone-Poulenc Rorer Pharmaceuticals Inc. His extensive governance experience includes being Executive Chairman of Cogent Healthcare and a director of
Allscripts Inc., Arno Therapeutics and Presbia Inc. Mr.&nbsp;Thurman completed Wharton&#146;s Corporate Governance program. Mr.&nbsp;Thurman served as a U.S. Air Force fighter pilot in Vietnam and graduated from the U.S. Air Force Air
Command&nbsp;&amp; Staff College. Mr.&nbsp;Thurman received a B.S. in economics from Virginia Polytechnic Institute and an M.A. in management from Webster University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Kathleen Regan </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kathleen (&#147;Kathy&#148;) T.
Regan has been advising and investing in healthcare companies for the past twenty five years. She became a venture partner of Radius Venture, a venture capital firm focused on the life sciences and healthcare industry, in 2010. Prior to joining
Radius, Ms.&nbsp;Regan was the Executive Vice President of Keystone Dental, Inc., a portfolio company of Warburg Pincus LLC, where she led strategy and business development. Between 2003 and 2008, she served as a consultant to Warburg Pincus LLC, a
leading global private equity firm, where she was involved in investing with the medical technology team and served as a board member to several portfolio companies. Previously, Ms.&nbsp;Regan spent fifteen years in healthcare investment banking and
was a Senior Managing Director and Director of Healthcare Investment Banking at Sun Trust Robinson Humphrey LLC and, previously, a Managing Director at Freedom Securities Tucker Anthony. Ms.&nbsp;Regan currently serves on the board of directors of
Aeris Therapeutics LLC., a privately held company focusing on emphysema therapies, and EndoGastric Solutions, Inc., a Radius portfolio company focusing on the treatment of gastroesophageal reflux disease. She also serves on the Board of Trustees of
the Lutheran HealthCare, a not for profit hospital, family health network, long term care and home health care system in New York. Ms.&nbsp;Regan received a B.A., cum laude, from Princeton University and a MPH from Columbia University. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Orthofix: </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative orthopedic solutions that drive
value for patients, surgeons, and providers. Orthofix&#146;s products are widely distributed around the world to surgeons and patients via Orthofix&#146;s sales representatives and its subsidiaries, and via collaborations with other leading
orthopedic product companies. In addition, Orthofix is collaborating on R&amp;D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation and Education Foundation and Texas Scottish Rite Hospital
for Children. For more information about Orthofix, please visit www.orthofix.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Contact</U>:</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Quick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director of Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">markquick@orthofix.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">214-937-2924 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g623654g08m58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g623654g08m58.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X0KZ17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P(#<N,``R,#$S.C$Q.C`V(#`R.C$W
M.C(T``````.@`0`#`````?__``"@`@`$`````0```*&@`P`$`````0```#X`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```)S`````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``O_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(`#$`@`,!(@`"$0$#$0'_W0`$``C_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`/54DDDE*22224I))))3%[BUI<&EQ'YHB3]\+COK1U3Z
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M?_!*6*QEA#+BXX@`@<0/EO%AA*4,G"3UH_Q?44DR=9[<4DDDDI22222G_]#U
M5))))2DDDDE*22224^<_7[I]F/UIN;'Z'.K`W>%M0V/9_:I]-[/ZEBQ^B]6N
MZ/U*O.J'J``UWU:#?4[;O:/Y;7-;97_+7J/5^DXG5\%^%E@['0YKVZ.8\?0M
MK/[[/_,/H+F>F?XNJ:[7/ZKDG*K:XBNFH&IKF_FNO=N-N[_@ZG_]N*[CYC'[
M7#DZ#AK]Z+6GAG[G%#J;_NEA]=NH=/ZGT#"S,*UMS/M0:"/I-/I7>I78P^ZN
MQOLWUO65]1NGV977696V:,!KGO?V]1[754U?U]KWVKI^H?51O4\FBBPMPNCX
M(_08F,`UUCW?SEEC@-E%36_HZ_3;ZW\Z_P!6I;>!T_"Z=CMQ<*IM%+=0QO<G
ME[W'W/>[]]ZC]Z,<1A'4RO\`P8R7>T99.,["OJ0V$Z22K,ZDDDDE*22224__
MT;_7OK#]8NM?7+_FGT;*_9=%9++LI@!L=M8W(OM)(W,:QKO1QZJ?3]2S])=?
ML_F[?5/JA]9>G]/NSNF?67J%V7C,-OHY#P^NS8-[JV-=N96Y_P#@][;$'K_U
M6^L/3?K8/K7]7J69Y>[==AO<&.!=7]GO$V.8U]=C&[V>_P!2J[_!65H_5NO?
M7OJ/3K\#!^K5F)?DL=4<BS(J<&!PV/=7_1_TFW^;?ZB2G)K_`,9W5#]2;,R&
M.ZNS)9A?:`T;8LK?DUYWV?\`F_6].FUGH?S/VC])_-?JZ?ISLG+P:\OJ7U^K
MQ<N]HL?C5VT15N]WHO\`TE6ZUG^$VU5_I$#J7^+SK>']3*L##I&7U.[/;E7M
MI<`*ZVT78U-;;;WU>IZ6_P"G^_:NKM^H71,_ZNU8;\&CI_4'45SETTUBVNYK
M6RY[ZP/6_2?S]?J?IOW_`/")*>;^J74?K)]9SG]'_;%_V?!L;9C]8I8UKW@.
MLJ]"QL-=Z>57^LUMM_3U>G^>Q5>O'ZS=)^M?3N@-^L.9:S/^SS>=K2WU[K<8
MPS\[9Z6]=7]0:OK)TS&?T/K.#Z5.*7?9,ZMS'5O:#[JW;7>M_P`)1;;5^DJ_
MG_TM7Z;/^MGU>ZWG?7WH_5,3%=;@XWV3U[PY@#?2R+KK9:^QECME=C7_`$'I
M*6^L?3>O_5WZN]1ZA_S@S,RPMHKJWPSTR[(HWVL<W=[_`$M]7_7%8^J'UXZ+
M7]7<)G6NKU_M+:_[1Z[YLDV/V>H8_P!'L6O]?.G9W4_JMEX6!2<C)L=265-+
M02&756O]UCF,^@QRJ?4_ZJ85'U;PJ>L]+QSU!C7B_P!:JJQ\^I86;[8LW?H]
MGYZ2GC^D_7?JV+D?63J1RG]0Q\5A.!3:\FJ;LK[/BV-'M=Z3:W>I_P`2M;ZM
M=&^M'UHZ<WK74OK'F8U>2YWV>C#(I]C'.JWO]/:SWO8_;7Z?\W_A52Z5]0^L
MY&7]8L3+H/3\//:[[%>#66AU>3]KQ0VNI[G,JVM;[=O\TM#ZO7_7KZKX7['O
MZ">I8U#W_9LC'R*VC:]SK'#W;GO9ZCOT?J5T6,9_@TE-//ZO]9?J-]8,3&S>
MHV=7Z3F0?U@`V!N]E-NVS6SUJ/499_.>C=^XFZI]:^J]6^MF7TFOK5?U=Z5@
MN?6^]^QKGNJ(I?M?;M=9?;>_VUMLIKJQZO5_2O1<KZN_6OZY?6+&SNM83>D=
M+Q-H;2ZQMMA8US;K&-]-WNOR+&M8^RQE%5-'^FL_G#?5WZGYA^NG6LWK?3&7
M=-R'Y#\5^0*K6%S\CU:GLJ<ZUS'.H_D,24DPL!N=E5XV']?+LJ]YW-IJ?4Y[
M@W](^&L>[\P*K]6.H]6ZQ]<^O])RNHY0Q`W,;0VNS::2S*KJI?CN_,?2P^S\
MS^1Z:[O%Z#T/"O;D8?3L7&O:"&VTT5L>`1#@U];&N]RX?ZO=%^L71?K9UWK-
MG3+;J+FY7V1C'U`VNMRJ[:&-W6_HVNK_`$CWV,_1L_\`!$I&WZU_6+ZD9N5T
MWZRBWJ]%C'V]-S00WU".&.L?_-U_1^TL_2V8+_\`3X]U2V?J1A_6;.<?K#U_
M.N`RILQ.FL)92QCQ[;'T_N[/Z/39_P`?=^L?S69@?4GK'UFS<KJWUTWX[GL=
M3AX55@_1`CVVU^F^VNME/^"K]_VB[]/D_N+0^IE/UMZ%DOZ!U3%=E])J<6X/
M4V.9[&\L8^KU#=]G>WZ'M_5+?T/Z3&]/T$I__]+U5)?*J22GZJ27RJDDI^JD
ME\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI__9_^T/
MKE!H;W1O<VAO<"`S+C``.$))300E```````0`````````````````````#A"
M24T#[0``````$`!(`````0`!`$@````!``$X0DE-!"8```````X`````````
M````/X```#A"24T$#0``````!````!XX0DE-!!D```````0````>.$))30/S
M```````)```````````!`#A"24T$"@```````0``.$))32<0```````*``$`
M`````````3A"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"A
MF9H`!@```````0`R`````0!:````!@```````0`U`````0`M````!@``````
M`3A"24T#^```````<```_____________________________P/H`````/__
M__________________________\#Z`````#_________________________
M____`^@`````_____________________________P/H```X0DE-!```````
M``(``#A"24T$`@```````@``.$))300(```````0`````0```D````)`````
M`#A"24T$'@``````!``````X0DE-!!H``````T4````&```````````````^
M````H0````@`:0!M`&$`9P!E`#``,``Q`````0``````````````````````
M```!``````````````"A````/@`````````````````````!````````````
M`````````````!`````!````````;G5L;`````(````&8F]U;F1S3V)J8P``
M``$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<`
M`````````$)T;VUL;VYG````/@````!29VAT;&]N9P```*$````&<VQI8V5S
M5FQ,<P````%/8FIC`````0``````!7-L:6-E````$@````=S;&EC94E$;&]N
M9P`````````'9W)O=7!)1&QO;F<`````````!F]R:6=I;F5N=6T````,15-L
M:6-E3W)I9VEN````#6%U=&]'96YE<F%T960`````5'EP965N=6T````*15-L
M:6-E5'EP90````!);6<@````!F)O=6YD<T]B:F,````!````````4F-T,0``
M``0`````5&]P(&QO;F<``````````$QE9G1L;VYG``````````!"=&]M;&]N
M9P```#X`````4F=H=&QO;F<```"A`````W5R;%1%6%0````!````````;G5L
M;%1%6%0````!````````37-G951%6%0````!```````&86QT5&%G5$585```
M``$```````YC96QL5&5X=$ES2%1-3&)O;VP!````"&-E;&Q497AT5$585```
M``$```````EH;W)Z06QI9VYE;G5M````#T53;&EC94AO<GI!;&EG;@````=D
M969A=6QT````"79E<G1!;&EG;F5N=6T````/15-L:6-E5F5R=$%L:6=N````
M!V1E9F%U;'0````+8F=#;VQO<E1Y<&5E;G5M````$453;&EC94)'0V]L;W)4
M>7!E`````$YO;F4````)=&]P3W5T<V5T;&]N9P`````````*;&5F=$]U='-E
M=&QO;F<`````````#&)O='1O;4]U='-E=&QO;F<`````````"W)I9VAT3W5T
M<V5T;&]N9P``````.$))3001```````!`0`X0DE-!!0```````0````".$))
M300,``````GH`````0```(`````Q```!@```28````G,`!@``?_8_^``$$I&
M248``0(!`$@`2```_^T`#$%D;V)E7T--``+_[@`.061O8F4`9(`````!_]L`
MA``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,
M#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1
M"``Q`(`#`2(``A$!`Q$!_]T`!``(_\0!/P```04!`0$!`0$``````````P`!
M`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"
M!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+1
M0P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25
MQ-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%
M!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C
M<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2E
MM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#U5)))
M)2DDDDE*22224Q>XM:7!I<1^:(D_?"X[ZT=4^N-=+[*,0X'3VB7WU.9;>!^]
M;L+OL]?[_I5V[/\`N0F^M7UQS\/.NZ5T]C:7T[19E.][I>UEOZ"KZ#=K7_SE
MOJ?\4I_XN\UU]?4:K[7W9/JLN=98XN>YKV"D2]W[OH*Q#'*$/=E&,AH1$ZZ2
MZL,IB4O;!(.NH>1HZUUJBT74]1R=XU]]K[6G^M7>;:G?YB]"^JOUD'6L1[;@
MVO.QB!?6W1I#OYN^K<7?H[(_ZW8N.^N/1*ND]3:_&8&8>:'/K8T0UEC?Y^IC
M?S:_<RVO_KO[BA]3LEV/]9<2)#<@64/`[@M=:W_P2EBL980RXN.(`('$#Y;Q
M882E#)PD]:/\7U%),G6>W%))))*4DDDDI__0]522224I))))2DDDDE/G/U^Z
M?9C]:;FQ^ASJP-WA;4-CV?VJ?3>S^I8L?HO5KNC]2KSJAZ@`-=]6@WU.V[VC
M^6US6V5_RUZCU?I.)U?!?A98.QT.:]NCF/'T+:S^^S_S#Z"YGIG^+JFNUS^J
MY)RJVN(KIJ!J:YOYKKW;C;N_X.I__;BNX^8Q^UPY.@X:_>BUIX9^YQ0ZF_[I
M8?7;J'3^I]`PLS"M;<S[4&@CZ33Z5WJ5V,/NKL;[-];UE?4;I]F5UUF5MFC`
M:Y[W]O4>UU5-7]?:]]JZ?J'U4;U/)HHL+<+H^"/T&)C`-=8]W\Y98X#914UO
MZ.OTV^M_.O\`5J6W@=/PNG8[<7"J;12W4,;W)Y>]Q]SWN_?>H_>C'$81U,K_
M`,&,EWM&63C.PKZD-A.DDJS.I))))2DDDDE/_]&_U[ZP_6+K7UR_YI]&ROV7
M162R[*8`;';6-R+[22-S&L:[T<>JGT_4L_277[/YNWU3ZH?67I_3[L[IGUEZ
MA=EXS#;Z.0\/KLV#>ZMC7;F5N?\`X/>VQ!Z_]5OK#TWZV#ZU_5ZEF>7NW78;
MW!C@75_9[Q-CF-?78QN]GO\`4JN_P5E:/U;KWU[ZCTZ_`P?JU9B7Y+'5'(LR
M*G!@<-CW5_T?])M_FW^HDIR:_P#&=U0_4FS,ACNKLR687V@-&V+*WY->=]G_
M`)OUO3IM9Z'\S]H_2?S7ZNGZ<[)R\&O+ZE]?J\7+O:+'XU=M$5;O=Z+_`-)5
MNM9_A-M5?Z1`ZE_B\ZWA_4RK`PZ1E]3NSVY5[:7`"NMM%V-36VV]]7J>EO\`
MI_OVKJ[?J%T3/^KM6&_!HZ?U!U%<Y=--8MKN:ULN>^L#UOTG\_7ZGZ;]_P#P
MB2GF_JEU'ZR?6<Y_1_VQ?]GP;&V8_6*6-:]X#K*O0L;#7>GE5_K-;;?T]7I_
MGL57KQ^LW2?K7T[H#?K#F6LS_L\WG:TM]>ZW&,,_.V>EO75_4&KZR=,QG]#Z
MS@^E3BEWV3.K<QU;V@^ZMVUWK?\`"46VU?I*OY_]+5^FS_K9]7NMYWU]Z/U3
M$Q76X.-]D]>\.8`WTLBZZV6OL98[978U_P!!Z2EOK'TWK_U=^KO4>H?\X,S,
ML+:*ZM\,],NR*-]K'-W>_P!+?5_UQ6/JA]>.BU_5W"9UKJ]?[2VO^T>N^;)-
MC]GJ&/\`1[%K_7SIV=U/ZK9>%@4G(R;'4EE32T$AEU5K_=8YC/H,<JGU/^JF
M%1]6\*GK/2\<]08UXO\`6JJL?/J6%F^V+-WZ/9^>DIX_I/UWZMBY'UDZD<I_
M4,?%83@4VO)JF[*^SXMC1[7>DVMWJ?\`$K6^K71OK1]:.G-ZUU+ZQYF-7DN=
M]GHPR*?8QSJM[_3VL][V/VU^G_-_X54NE?4/K.1E_6+$RZ#T_#SVN^Q7@UEH
M=7D_:\4-KJ>YS*MK6^W;_-+0^KU_UZ^J^%^Q[^@GJ6-0]_V;(Q\BMHVO<ZQP
M]VY[V>H[]'ZE=%C&?X-)33S^K_67ZC?6#$QLWJ-G5^DYD']8`-@;O93;MLUL
M]:CU&6?SGHW?N)NJ?6OJO5OK9E])KZU7]7>E8+GUOO?L:Y[JB*7[7V[767VW
MO]M;;*:ZL>KU?TKT7*^KOUK^N7UBQL[K6$WI'2\3:&TNL;;86-<VZQC?3=[K
M\BQK6/LL91531_IK/YPWU=^I^8?KIUK-ZWTQEW3<A^0_%?D"JUA<_(]6I[*G
M.M<QSJ/Y#$E),+`;G95>-A_7R[*O>=S::GU.>X-_2/AK'N_,"J_5CJ/5NL?7
M/K_2<KJ.4,0-S&T-KLVFDLRJZJ7X[OS'TL/L_,_D>FN[Q>@]#PKVY&'T[%QK
MV@AMM-%;'@$0X-?6QKO<N'^KW1?K%T7ZV==ZS9TRVZBYN5]D8Q]0-KK<JNVA
MC=UOZ-KJ_P!(]]C/T;/_``1*1M^M?UB^I&;E=-^LHMZO18Q]O3<T$-]0CACK
M'_S=?T?M+/TMF"__`$^/=4MGZD8?UFSG'ZP]?SK@,J;,3IK"64L8\>VQ]/[N
MS^CTV?\`'W?K'\UF8'U)ZQ]9LW*ZM]=-^.Y['4X>%58/T0(]MM?IOMKK93_@
MJ_?]HN_3Y/[BT/J93];>A9+^@=4Q79?2:G%N#U-CF>QO+&/J]0W?9WM^A[?U
M2W]#^DQO3]!*?__2]527RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI
M)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V3A"24T$(0``````50````$!````
M#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'``(``W`"X`,`````$`.$))300&```````'
M``@``0`!`0#_X1)(:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP
M86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y
M9"<_/@H\/V%D;V)E+7AA<"UF:6QT97)S(&5S8STB0U(B/SX*/'@Z>&%P;65T
M82!X;6QN<SIX/2=A9&]B93IN<SIM971A+R<@>#IX87!T:STG6$U0('1O;VQK
M:70@,BXX+C(M,S,L(&9R86UE=V]R:R`Q+C4G/@H\<F1F.E)$1B!X;6QN<SIR
M9&8])VAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN
M<R,G('AM;&YS.FE8/2=H='1P.B\O;G,N861O8F4N8V]M+VE8+S$N,"\G/@H*
M(#QR9&8Z1&5S8W)I<'1I;VX@86)O=70])W5U:60Z-#`T9F8Y-#(M-#8U8BTQ
M,64S+3@U,6(M9F5F8SDS9F8U-F1E)PH@('AM;&YS.GAA<$U-/2=H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO)SX*("`\>&%P34TZ1&]C=6UE;G1)
M1#YA9&]B93ID;V-I9#IP:&]T;W-H;W`Z-#`T9F8Y-#`M-#8U8BTQ,64S+3@U
M,6(M9F5F8SDS9F8U-F1E/"]X87!-33I$;V-U;65N=$E$/@H@/"]R9&8Z1&5S
M8W)I<'1I;VX^"@H\+W)D9CI21$8^"CPO>#IX87!M971A/@H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*/#]X<&%C:V5T
M(&5N9#TG=R<_/O_N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#
M`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__``!$(`#X`H0,!$0`"$0$#$0'_
MW0`$`!7_Q`"D```"`@(#`0$!````````````"@@)`0L$!@<#`@4!`0`"`@,!
M`0`````````````!`@,(!`8'!0D0```&`0,#`P(%`P,%`0````$"`P0%!@<`
M$0@2$PDA%`HQ%4$B(Q8743(D<8%284(E)A@H$0`!`@,&!`0%`P0"`P`````!
M$0(`(0,Q01($!0;P46$B<8$3!Y&AL<$RT>$C\4(S%&(54B0(_]H`#`,!``(1
M`Q$`/P!_C2$&D(-(0:0@TA!I"#2$&D(Z%D/)53Q=`.K';7,HFS;D`4F<#7;!
M;9^26.<$DFD-6JK&3$_+O%53%*";=LH(;[FV+N(<K*9.OG:S:-$-!-[G-8T>
M+G$`<_`'E&"OF*67IOJ5"4:TE`"20.0%I^\+$\^/-/R9AY26QQ@W#=ZXW0AU
MW35MD_,=#EXS(UB2;*G3.I5*]98S]K5UNY3.4X&5&1?%3V,4J`[[;+>WOLSM
M;/91NL:QKE'4G-"NHY>L!385"-J$.%1SE_\`'"T@F:J!X5O+W-US*O.3TW3*
MN0:<(%6M3/J.:6G\6D%@+KE4R6212@3G'S30GPM:7*_D&I-).UWH.1RK:UF2
MBXJ`90AH):4-7#-A*'3VA:"B!1V`O3Z:]SK^WVR795^79M?*"@6D8338U$PC
M\@XU`;CW'N*A5)'ES=W;IHUBX;AS@=B)1S@3,XICN;:39<DT"0PUXP?,G9,M
M7J!XY<KW,0-SLHFCL=9?;,6\&E:K+^06U/N<0P*G"L)R43."<<]9IMF[M<@(
M*(E74(=77?W1]F*>AY3.;DVM2J#3:;R:F7+A4<Q@3$]I#G.<&@@N']HF"0"G
MK^Q/<NOJ6;HZ)K[Z?^S4`;1KDAN-Z`87M`0$F\(.8$,B%5*8W0&_5Z_]H[`)
M0*)@$?P$.H-:Z!"'$&PI'MK3B#IA6E#^W,1]-(F#2$&D(-(0:0@TA!I"#2$?
M_]!_C2$&D(-(0:0@TA!I"#2$<9XY19MEG;A9)NW;)BLNX75(@@@@G^=95993
M]-))-,!$QC"!0`!$1`/74AKG.:UOY$H`BDFX`"9)L$02&@N<0&@*22@`O)\!
M.*5.:/FQX]<>@EJAA4[#D+EMD9RP5:0$F=OC6LO4G":*IK%>6R2R4NJ@.X^T
MB`=&$0Z3K(^IM>R[(]D]Q;F-+-ZNQ^0T9XQ%ST]9S00/XZ1<V2FUQ:@%ACS+
M<WNEHVAEV7TU,[G)A&$%@-RNL*34`BRV.]<!<A)^33A/:I;EG7:9D=.U92R=
M5YJJD@R1\#`Q4:[CCUR-@$TSFDHYW"Q$BD=O)%<FD2J'[@+]0^GS=^::/;7>
M>4I[6S>8HU*>5I/94+NYY.(5'$`D87.:1@<$03"&?*V;GCO';5>KKU%E9KLU
M5:00T@`$!J25J*41RI?R6"\D_!*:X,9O"N,'<E/XBR`A*V#$MJE2-C/EV+)=
ML2<J,RLBFF5:P5!9XB4RH$3!TU717*7J.H4FSWMMONEOC0'UJM.G3U;+*RNQ
MK::*Y"Q[<4P*F%RB>`@M"`QX1O;:#]H:FRA3+G:75&*D\J2"3*F3-2%4FWI%
M?@G=L7"+Z->/8V18.SOHV08KMVCV/D&)VJ[%\S<LUQ5;.FC@A5$SICN0Y0,F
M(B`B'I=2FVL,Q2K,#J+VU`X8:*%N!I<T@D`APD1>)!#;TICBRI0JC\Z9!:9J
MT\P><;#7@-GA]R6XD8/S'-.$7%HLU/1:7,[<3]L]SK;A6LV=84Q_(@9Y+0ZC
MCH+^0O>V+Z>H_G=OK0SMK=^O:*VF!0I9AV!"H%-QQ,0V$87`*#:(W,VEJO\`
MW>WM)U*H/_8?2[IKW"3C:;3-#9$Q==3CLD&D(-(0:0@TA!I"#2$&D(__T7^-
M(0:0@TA!I"#2$&D(-(1%SF]$S,[PZY01-?640F'V!\HI,3I'4(H90*?+*'1(
M9+]3J<HD,GL']W5M^.NQ;0?1I[KVV_,-!HC/4%6Q/4;/RM\H^%N=E9^W=;9E
M\7K'+5$PVDX3(2-MEE]UL:Y=J4@-D^@$RE,GU$!/L=LI>Z7H`H>@$*!`#T``
M`OX?EU^CSVM!=V%$>G91L]8)?Q8.V8TI8@:QK24'-55%/P)2:V3Y0R+\?#DN
MQJ]XRGQ:LDDFW3OZ?\F8W3=O@206LL"V:15S@F;<3&!61E8`K5\F4H"84XU;
M;\=:U?\`T-ME]>AI>ZLO0..BZI0K$-:!A<\NIN["@:'*TK87`!1'N/L[KC*&
M9SVA9FHUK:W?25`KP$+!U-H"J@)`BU#S782C,M<$<CVM5NU&QX/7C\I5A^**
M9G22<?(-HFSQA7"I1,W8RE9D7)E@(.YE6Z([")0V\F]F];?I.^M/RY)&3SBT
M*@N[@2QR&1<UXDMQMCOWN;I&6U':N>S3P37RO\K"%N+0\(MX7X"=JHXG,4_=
M`.D=O<!OTM]A`Q";!Z`4!$`#UV';_CL&^^^%2GA=4)II_E_MHBQK>LOM_:IL
MU1Q`82"H`:;Q:%X^:60[9X(V$NPX`5!23262;2N3<N24+W>]TGB!LQ&9%6X&
M)V^PI(M'(AL/3OOT[@([:/\`OIZ+_</4O2>264*(<)`AQ:20X`H")2"^4;3^
MU%.LS:&4=7,C5JEDU["1]"L7,:\=CTN#2$&D(-(0:0@TA!I"#2$?_])_C2$&
MD(-(0:0@TA!I"#2$<*28LY./>QT@W2=Q[]JNS?-5RB=%RS<)F1=-UB!MUI+H
M',4P?00'UU5Q>W`^FXM>UP(()!"%9$61!8VJUU-[5:X$)S4(GA&O)YW<6)WA
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MH.#%50"IKK$'J+J`-@T=H>[&W-*R>K4<UE'9L5,#7XZU%K3B<*R*&EH!0`I*
MP!%V2&Z\UKOM]K6?U'2JE#,LH$.5J,J6`/IDA"TJJ>1A6_"N$LC<C<GUS#^)
MH)><N=M?"S;@1LL$5!,"]H\C9+&[;H'^TUR":=3EVN8@@"1-B%,H8J9MKMQ:
M[INW=)KZYJE=K,HVF]V)PICU'!H#*;"#-[W2)"X1.TNC7?1](SVMYS*:7IU(
MU*Q+0Y)EK40N*I(<R0#?-(V'/&C"$%QOP3B[!U;<+/HG&U2CJZ237#H6F'Z9
M/<S,TLD`%(DI,S3APZ$A?0@J[?AK\\=PZWG-PZ[J>M9MK14S59ST!7""F%MU
M@D.@$;EZ-I-#1-*T[2Z#\3*%(-5`%-Y(%YMYJ2L>ZZ^3'U(-(0:0@TA!I"#2
M$&D(-(1__]-_C2$?GK+_`,B_7;ZA]=A';Z_78-_]-(1D#%-_:(#Z`/H(#Z#Z
M@/I^`A]-(1G2$&D(-P_K^.W^^^VW^N^D(-(1@P;AMN(>H>H;?@._X_UU!DA5
M$@@*@A1$'>;_``/PUSGQXVJ60"+0%MKIW;R@9,@D6REEITBYZ2ND0(L!23-<
MD%$R"]C53E27,F4Q3)K%*H7N.S-\ZOL;5#GM/>*F4JMPU:#YTZH4$$BYP23K
MIR(41U?=6U-.W7IYRF;:&YMO^.J`,3%MGRZ7\Q;$%^'_`(,>.>"W+&X9T>)\
MC\ALW;URT;SD>,;BN(W<)BP]M0E7#\DZ\;I$ZA5DUW"!3F'H0+L!M=ZW?[X[
MCW`:V5T2E_UFGN"$TY5R9XB*K0TM:5L:+AW$1UC0/:K0=*-.OJ9.<SC2"W$W
M#31)$LFKN:N(-J":ROYH<,K%S0)C["$[;T\6<6:B^:V>[P=*!NE>LFR\0*"-
M5J4*(L_L]'IM91,JJHX$CE=9V9`$FY"(%5-T_9N\Z6R:^=U?+Y;_`&MS5J;F
M4W5>ZE282"^H09U*BX0T20*I*D#[NYMMOW73H:36K>AHE-[7.#%#ZCF_BT))
ME,6DD.5!VHAB2O'SBO@/BY4PI^#<;U^C1ZJ2*4K*,T!=VFRK))@0KNT6I\+B
M>GG7<$Q@]PN<B9C#T%(`[:^%KVZ-:W3G'9S6]3?F*X=84#&GDUC48`B"0LM6
M/M:3M_2-#R_^MIN0;2:6H2/R<"@*O_*:"PB841(;T`/KZ`'J(C^`?B.O@J"4
M!"Q]A$C.IA!I",`("(@`@(@.P@`^H#L`[#_0=ATA&=]0H%IA&`$!]0$!#^H>
MNILM@01;&=(0;AZ^OT^O_3\?72$&D(__U+7?-WY^;EP<R]'\,N'U,K%WY,.X
MVM/+Q;;DPE;!!8Y<W=N5[2:=7*5%G9+W7(EFC5V[P"*N2,F+1V@)DW2JO93C
M$&J2%"<TX2,M-@<J@DS^EY3Y7\Q'1*-QI^5%ERHPV2+ESYXYX&L,ZQCIIKB"
M3I-3-+PGO&AWR<'9?VO@N?@X^3:F."*[<CR0`.DW6KUD$NJN#T<&."I?.<55
MEJ&(@0OGA\G/C*YDL>+GETJ&/LDTHQZJI,7S'E=B8&U(T.RJ2#..RWCR7K#>
M&JN1:^B[BW/N8YY&Q4@(-7*1C-G20(JFN('\A[NE@%P\1SOM061<,:\`,'=U
M-IYHEG!B>OFM\^UYX6Y$Q[Q6X85.HY"S_>ZI1;M-7>U1TE:*S7(7)SE1#&]?
MI=2B'D6\N5XNR2(N$06539MVRS?\BZBX@C(>)'"H3CSB*;`X`DBV]1QQTCJM
M,I7RU[I4H6Y2F<N%V,WTVP922F.K96**-I@O>CU_;988+$EKA6\FBB).I$DJ
MOTJ&,F<Y3%WUC<*HL>`?UL\4Y7\X#TE<H<G'%D17XC>:3RLWWD_F_P`6V?5L
M`1?,:3@\H8YPKF%C7X]E`XSY)4&(F)J,;W]A`-+%3[KCR>;0BQ4G+.+3<(N1
M2!1(Y#G!,'O0@L=BQ)9=+K,":F2V))3;#3&%QFV:SF?E+YVJALCT'F;D_P"3
M7P2XXWSE!F?E?PKEL>8\4J24\PH./H28M*BENND+36'VV.G<(5R-<$2DK"W,
MJ)G:8@GU``#T@(V)J`+*"472;BQ2O$YSNY(/(E9H/+O'GRM^2)Y,<06G-G'K
ME5P_AJC4<@2>-9-GDW&E;@9M:PQ,5`SSE1BA7L,VIJI%C&V!$I53K)J"X*<G
M1T@"NH5^+"2.!X\XJ13;)'+X_MY_*.'Y7O)GYI/&%BSA]3<D\B,%.N0N18CD
MC9LJV3'^,*39Z/-0]>O--98M1BR6?'L$>+=PE?FU47H(LDBJNC@4YE0`%2W4
MBT6FZ[C](`,)(;8@1>:\OL/VAQGC%<[+D;C7Q^R%<G(/K??,)8LN=J?$8HQ9
M7EDM%%@IN<=DC6I?:1Y7,F^5.""(=E(#=)`Z0#0$ER)=&-W;"FD!YB^>SKY`
MDAP/D\MU,G%EIRJNN-3U%7&5";RZ-"@*#)6!%D-V"%+8.MF_1(JJZ,X[_2!2
MB8Q3&Z:!SBXB[CCE&4MIAF($*GFLIV_#I='0LL>?'R)\^^:2_#OQ`T[']7@?
MO-JA8/)5X@HVP6JQP=16:M+'EBQ+VQ!]3L<XZ8&6!9%,8Z0E#H+H"4%73A-H
M07F9L:!:?C\$^$"QK0"XJO(V2Y)<?HG6)=6/BK\I^@UZ0R%7?(/QGRM;6#62
ME2XE;U&KL4YE?VR*Q(&%=V?`4/65':IF_;0*NX8HD,81!8O480L&D!H:Z7F?
MG%1Z1)4.L*>-WESX7A^%3Y`>6N67()UP7YU4>KT_D4Z>7&,H%WIT0[JC"?M6
M/6;Z0N>,,@4MV\DT:U>8QA#/G#=VS7!B\!JH@+=!8"=V`\*&D%2(L^B6EY:5
M:#]HCKE+SK>2OG+SQM7#7Q$8\Q=%UVHS]L@4LB9)KJ5AEY2'HJQ(NV94MLE-
M/OV?0,?)39RIQJ`,G\@\1<-3!UN7(,2"YQ(PE/UX6*X0UG>TXB0D[D\+;+Q*
MZ)GM<(?*U523.IS,\?J"ABHF.B-,;*G3$S<HG3.)..2R?650`]2G,4Y!$VX#
ML&H:VKA:'5`7),HBGP67A]8DNHJ4IE.IZ>'.?A*(&>4[R.>:SQ>XIX=U;+'(
M[!<OR!RM*<D)7(UFQ[BFGV&D2M3K<EC,N,(V.0LN/:V,?,PC29DBN!18(^[!
M4HJ*&,F0!(\$J_A91+!3=+"53]?'I\(G5S:SQYFH7QY\2N?G"W,E?L[28XKX
M@R/RIQ*;"F-[384I*Q8\K]HL&8\;(.JVX>OX)%>174F(-(Q3M&Q2NF@=LBR*
M=Z@>7=KB!-><[YV)X)TB!@(>'?G:#9S4&5\DL`\XX?''Y0G%FQ>/V=S[GH[*
M)Y6XT;P%/L?':J+=J0RU?;"V63J%JQ<O(!VB8XMYFBCM^Y5%0]<327(N50?:
M>Z@.N0^//CPOBA`7ITXN\8^7@\Y+^97R+VMURLY+93J.,^$"4M.JTN@UK#U&
MAIC-$N+MRFVAZ39I2N.[4CA^DJF!JZG5'/OYEVV,V;J`)'+DM@09@%(O4:UA
M:&N!!:+%D;P5`F.BCD3#4FIC%'__U8E^;YM/<8_/PEGS)];D4\<R^3N)^?JR
M]'W"K&ZX]QM7<:0]U4A"=GM2;V"FJ%(MG+8INHBR::@A^HF!\=1"\G""/"Y>
M)1S&N:*3@P]Y>MILF++$\[YQL0L5<CL#9PQ]!Y5Q+F''%_QW98MG-PMMK-NA
MI")<QC]N5RU5<*%<D5C7/:-LJW<D1<(*`8BA"G*8`NH%ICB`$J@C7P?)YY+8
MHY@\^,.8NXUSD9EZ:Q)C-+$4[,8^D4[&VL.4+_=I-ZRQU77$&C()6-_"`FW(
MJDW.H0SU\=+<JC<X&Q//>T&Q)%+_`->B1RJ*-9B3N#N9$DZ6#K*/&?(IA'(`
M^:GCGQB9Y*EL>Y18T_QE8,895B57,G-4:\M\0XQJ2-YBF)%HM1[(0=D3,_13
M*Z;&=*IANJD(`;48>\-#2&@)9X7JL31<VE0*2(22]3+#9%S7/3Q@^9WBQQFO
M6=,5>7GESR?=X^:LYBZXNBYR^4&R+8]:"X/<+379)#)MI7FY*M1P^Z6C4T45
MWC))7MJ=Q,B:@LJS=ZJB91!RDA62&:WK=&*G@>]C?2F2+S_4+T4\HZ)\5+#O
M!C*5EOO)64N-ZN_D,QS]_"?@LB6IM,Q,%2\A/#QI,QXY0!N64M+VX)/%H>6F
M)-PY>LG9ED.A(CE%9QD:UJDI->%B:V-N%CB<(%BJE_W/6V+O_DC^GAWY3#OM
ML_PAZ]73MOGS&1?[@`1+N([?0=]]OH.X2\*QX2Z,5.52F?\`D.E_.[QB#GQ$
MC]SQ^YS-W.Y_^M;>4#>X.Y`>G&N,"[=TZ2)AZ1#;IZ0Z/[0W`-]8J0(+\:_D
M4D@1!\;YF<7KD%Y3ZK>;^.<5R?,A<@URUP?6$P?HXJSNN*9G:C8IP3MF,@V$
M"(+>AA-T=6PC^;HVV.)BVJ!33DO=R6X]9>,_")HG_)-++TO^?Q$2MP%\<_+V
M3,#X7R)'^8+FO1V5^Q#CZX-J;#K3X1500ME2A)Y.M0Y4LN-2(QU<3=@S:`1)
M,$T$P*!0#TTP._M>0!9]HAU5CG/+Z:U7&94\YRXOYRH/XO8"EL-?(0@N,#O*
MMKR?8:?R%S#BI3,5R>N$[=<99[A.XQB%LG3J.9A8DF1U-$`XBY6,D4I2E.;J
M$2T:"7K:0;?!>O'*.4YZY4C$@*]JF2EI$D*CS"@*MT>I?'3SIC[@7Y1;YC?E
M:_B\-R]DQOD;CDZE\CNRUEE1LM0-WI$LC69]W*E0:5@L^I7'#8JKA0K8JJC?
M942.`,!20YKR6M(\$MFMW'@,+V^HUCJ8!=9:5D`DN7@3851)[&*_9^P=BVB3
M&3<CY>QO2L?0$0]G9BX6*YP$;7VD5'MA=NW8R*[\J#@B:&P@5,3G4$Q2D*8Q
MB@.<.:"&XAB3SE'%0R<`46-<9X[Y21YC_(5DN06$(F51Q^'(WDGR9>RD>W?`
MRJ^)T*W>EH69GDB-420Q+<[F(YJB182F%_)EZ0,IU$#&@5Q'XR/*SCI'(+QZ
M<YNF.=H`7D@0_*/+/!=PTRYSAY3Y]HF(N968>%MBI^)G=SF<AX;&56L%PCG^
M0:]'+4R9^VW&DN$(HS]ZG)@47#@HNVY%1+U>@4#7.;^4YW(O*S]?*.15JL8H
M<W%2(D,1*%`IX'G#5$?X#>;C20CGR_GHYU2"#.2CWSA@Z+<#-Y%LS?HO58]Q
MOGHP`W?]G];\I@.H83B'T+JS&5FD8WC"+OW\?EUCB^I0(!;1*'_ET\!PGA%8
MGS(`%*\\`@,8P_\`IW(A`5#&$IE3"]Q2/090-S.#*`F(BD(`4^W4)@Z0WR._
M(&S[<>?6Z)HN:'/-@^'''@6%<=\Y,!>/SPV\-<_\@K(1A!,.'W'2-J=38.&S
MFXY1N;K"M:<PU#HT:Y4;?>I^9%`PB<_;;MFY5'+DR2*9S!+G-*F[SC$1B=*-
M?Y9N'W*?G+C_`)9^4K"?%&NX]XW0.4CV1QC6AMY5W6F,'(OGKF]AC2M';MG-
MQJN,T4"+6YRR%B@8[Y4[-!!-!9NUP$/+P<(PS"IU\;.?`CG4ZC&,P.JJ"T%&
MDMF!89)B%QL6^:P_KX2?*;@/R&\9*K6J9#4G$&:L*4ZO5G(_'BKKM6<15X:*
M;$A("WXOB>HCMWB&;19D38GZ`5C7!3LG&YDTEW&5I#1.7T\HXE6F6$*X%0O'
M"Q=AJ\8H_]9JKRQ(^+1Q@2/0\IKO%K'&:\J[1H+RVEL!\E,[0HP4*\=8<+CI
ML[R\:PHL#`9R%?25,*)2^X(9/8!J<*S_`"2+-QKV*O1?M"EPX,^(H\<.7,1S
M+Y;1307"!WD?%U?E\HP*/95Z$GQY7BG)/>ST"/<[ZXCU@'6/7MK&T4E?A(59
MV6R_9>L<JI_MX68UPH$1+)I9T7"L\-DHM[\1-;^-K6<Y5^/X#Y`@LB<FO9*F
MH4YG=EF]ED@4RQ[X'Z>*TL^TFC07WY2+[XN_V\S^Z>VZNX()>FKC"HG-2GWX
M^$8'^JIQ+8/A=Q;SCN7+2D^"M_Y?J+8>1.8,N0GD=1R5QE7JU%B8SD@K1'=U
M8MZQ_![)X[K.+9?$18^8;IQ_OA7F4FI0/_FG0]>FSD+A<Z<"783VC#\OK;#-
MY^WT#W.CHZ3=7<VZ>GI'JZNKTVZ-]]_PWU-T8H4\XY4'X]SGRDM9_A_FW-<?
MS>_ERZ/VE(X^1/*0^&_OB#I\.3H5%W6L1/L&_P`.O3IN0F3A,?MD$3CNNFGV
MA+$EE%SBPC$..%B[?RIQ'#.=X.Y>C.?]ILU,XJN'5`_D:Q5!O?75@8N4LBU5
M6G`P0QE7+7=#^XNA(])3VC%8`1.<5>E'N'+#D0J914*H2V(_>$ZN>-6L\:LA
M,O%[?K]D/""V:)MS<9;(;/+K*8:9--5:DG*1[9/,U*HUF-'DKZ<<H0R+95GU
M*&`BHF`Y2P,*R)BU3%B.(=T15\ZE-\*]HN6`%?*]EC*V.+(TI61TL/ML=1W(
M-\VDZTM+U4UV<R!L)XTOK1-XT>IL2I@^4;KBB=3M$.GW1*=A[<7.7C/[+$L+
MD(:./I;%[N`F^.&N"<,-L//G,EB-MB?'B&+Y%X233=O\=)5"'3I3UR28:,)<
MCAU6BMCG!R@@X`QA[B9#[E"]T8S^1YPN17J/X#R>:!S9(C,>7E?)S_\`1=G=
MN:`M%\F0HO\`-2E1>IS,89XXQ6GB+[6A6A7.@;[W]M'8W:5,;<NL8P8BEO\`
M6,O\OIR7TY_;]H_M^8RO_'1LF558WR*WBI8_Y('CV)I^P89:9?>YJ1CO8-`@
M29.1P#4+LL/_`(\41B?W0R,MV@_Q!Z.L!L["HQ1%/U.[TUL*^"3XMBDE/!7Q
M"6Q6;E]S/Y;OXD)!51A'R%6Y>$BQ=',V!-%D=EQ/9/?TG!`%$4E^L5CGV,)O
M[<;A2PG$92C.N:_D[>U"O*R=G1$AI_Q.M/$$UP/D%EXO)/',C2$2E0S!+0Z=
MU)F-TJ$:Y*R>9-3RC'L<P%2.S]P:-!\V39;][V9`'N!K(@+2&F4<9RXBML0O
M\*-*\&]:Y%9G>>+S+N5L@YH<8K,ADR*OT;R)91[#'?[TA5#/(U3,>,*1!G4_
M=A6I!!BY67W$=R=/48):@5.#](L\O],8QV_/];(9?#Z!_H'U^O\`OJ3;&)J8
M0EB0NYYSZAX8[19..!O*UE+)V.)YE#9/#"R>.X_/SX)>'7<TP;X:7'"F.;XB
MDBS<)18)_<3-=Q4'M`?8_34I?%VDA9*(A9Y`<:_'I?P'#-?FSR"Y50N/6_%7
M%C3B$S"%YDJXW?8#85:!0AI2"-3,(RT`2W34.2.7M)7JJ-C(J=J$FBA_BIEH
M?308C*,E,U5_C'<H^/2&?.-W_P`[AQRQ&'&,:$/&<,;5_P#B,:)[3]ACCC[4
MG]I&,V`">T%CO[GW'^1WN[[G];NZR7",5_6%A^)6//CI.?)%5IS@]G?/;#F*
M;*%SDJK3<#P_+,^+"+)/GJV0X!!TRPT]Q$.#7+8JJ4B=>5&L!&F1$KDB'M3A
85!*?']>+8R.-3`,0[>./ATAO/5XQ1__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g623654g50y22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g623654g50y22.jpg
M_]C_X0NS17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``+<;````G$``MQL```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q,SHQ,3HP-B`Q.3HT.3HT.````Z`!
M``,````!``$``*`"``0````!```!MZ`#``0````!````10`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```I]`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`&0"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`[_K^9=CTUUU=0HZ:_(<*
MJK;:S?8Y[G-K:S&Q@^K<[<]OO_3_`,NK\]>:?6'IO7.E]0_RK<^ZVV759>]S
MFV`<^F]VUU3Z_P#0_P"#_P`%^B5'*R<X]1LRLBQUN=5:27V$EV^I\AFOT6,L
M9_-M]C%ZAUNK$^LGU5LNQX>'T_:<1VA+;6`O:WOL?NWXU_\`UVM7XQ/+&%U*
M,])&OE_PFA*0YF,P+C+'K$7^<7G?J3];LO[97TCJ=KKZ[R6XN189>U_TO0ML
M?[K:[?\``O=^D9;^B_PE?H]OU+J?3^E8;\WJ-[,;&K'NL>?^BUOTK+'?F5U_
MI'KQ;$LL;DX]M$^JVVI]4<[@]KJ_^DM__'B_(CI#`2,8F]Q`)@V#T=N\?1W-
M8[]'_P!=4?.XXPF#$5Q#4>(9.2RRG`B6O`:MW[/\;GU1:]PJ.5?6SFZND[/C
M^D=79_T%N]!^MOU?^L.X=*RVW6UC=90X.98T:>[TK0QSF-<YK?4K_1JYT>CI
MN-TK%JZ4UK>GBIIQO3^B:W#>VR?S_4W>HZS_``B\H;]GQ/\`'*1TCTVU,M=Z
MC:XV`_9B[/;[?;['^OZK?\'<JC;>_P"K?XQ/JCTG*LP\K.#LFH[;:J6/LVN&
MCF/?6UU6]CA^DK]3U&(73O\`&7]3NHY5>)3FEE]S@RIMM;V!SC]%OJ.9Z;?^
MN/7F_P#BU_YQLLS<[H?3<;J.0TL8^_*>&OK#A82*MSZW?IO\*K.?^V_K]]:J
M>A]:;B]&RNG>HU[(=ZKVRQ]S*B76LR7M8SU\?WUU>CZM_P"D8DI[BS_&O]3:
MK'U69%S7L<6N::7R"#M/YJC_`..W]2O^Y-O_`&R_^Y:/^,'_`,1G5O\`B/\`
MOS5C_P")W_Q'_P#H5;^2M)3N8OUTZ#E]:KZ'398<ZUC;6--;@W:^EN<P^I]%
MOZN]6OK!]8NF?5W#9F]3>ZNBRT4M+&EYWN:^P>UO\FIZ\QSCU<?XX<H]%&.[
M/'\T,O=Z4?96^IO]$ML_F]VQ3_QFV?7=W0:!]8:^GLQ/M;/3.&;?4]7T[]N[
MUWO9Z7I^JDI]$S_KC]7>F]-Q>I9V6**,ZMMN*TM<;'M>WU6EM%;7V_1=[W;?
M3K_/6&W_`!N_5(N&[[574XP+G4^S3^JYS_\`H+@*&XN1]>.@4=9E_3OL?3F4
MLMUK+#B4OJKVN]KJ+,]SO5_P?\[O7M^77B68EM>:VMV(6.%[;0/3V1[_`%=_
ML]/;^\DIK=.Z[TCJG3SU+!RZ[L-N[?=.T,VC>_U_4V.HV,][O6V>Q8.1_C4^
MI-%AK&<ZXM)!-=5A;(,:/+&M?_6K7D_1;,BKH/UJ^Q/>,`T4-<_B=V7370U_
M_&8S\IO_`&XNO^H3?KWC?5O'LZ!@],=B9!L<;[]XOL<VRRHF_9;6WV;/3J_X
M))3U>-_C.^J657DV4WVN;AU>O=^B>(9OJQ]-/=^ER*T2[_&)]7*.F8_5GNO^
MP9;WUU7BEY;ZE9@U/_T;W_3JW?SFRS_1K*^MEOUBL_Q==7=]8JL>C,#ZQ6W$
M+BPU>IC;'.]1]KO4]3U5#_%_3TJ__%KZ7616[ISC?]I]4PP,%A=NW?28YCO?
M6]GZ1EG\U^D24]=_S@Z-^QOV[]KK_9?I^K]ID[=L[=NV-_K>I^A^S[/7]?\`
M0>GZRSL#Z^?5_/QOM=#K_LYL;2VUU+P'6._,KT]_I>WU=O\`I:O](O%'"L35
MZF<_ZFMZAI8&@.+MO;=^K_;?LG_I3TF?S:]YZ;@_5_*Z1AMZ?33;TQC`<,-$
ML#?[7NW._P`/ZGO>_?ZZ2G__T+?UX^K&5C=0LZIA4NNQ,MVZYM;2YU=SOIEU
M;=S_`$LAWZ3?_I_4_P""5CH&/]8/J]TK+S<YS<;`L8[TL"P%]]E]C=F,**Z_
MZ-9?<ZMGIN]6RS_N-5_/+T%4\W^F]/\`^-?_`.>;E?/N^Q'C$.'3?Y^']'_"
M:$?9]^7!Q<>NWR?UGB/J=]2,]N7C]2ZK7Z%.-%E..[^=<]H!ILM8/YFNMWZ3
M8[]-ZC/TE=:[;K/1.F=<P78'5*!D8[B'AI)!:YOT;*[&;;*W_P!3\S]'_-O5
MU.H.:]WW/UE;>GA^7A\&QROM^W^KVOU7\W%XO&8_^*_I^)2[&P^L]7Q<9Y)=
MCTY+65F?I>QM.U:/U?\`J']7OJ_5<W`K>[(R&&JS+M<'W;'?FL.UM5?_`%NK
MW_X1=$DJ[.X/U4^IO3/JK7DU]/MOM&66.L^T.8Z"S<&[/2JI_P!(A?6+ZA]&
M^L&?C]2OLR,/.Q@`S(PWMK>=I#Z7.<^NWWT._FK*]C__``-=&DDIH=4Z/3U7
MH]O2<RVQU616*[;F[&V&(]_\WZ+7OV_Z'9_(0/JU]6\'ZM=-_9N#9;93ZCK=
MUY:YTNV@ZULJ;M]O[BUDDE//U_4GI5?UJ=]:A;D?;W3-1<ST=:_LOT/2]7^;
M_P"&^FK'UH^J_3_K1T^O`ZA9=535<V]KJ"UKMS6V503;7<W9MN=^:MA))3S?
M5/\`%_\`5SJO3<3`S*GEV!0S%QLQK@V\5UAK&;GM;Z5OT?\`"4^G[[/3K8L^
MW_%=T^_%&%D=9ZO=A-`#<9^2UU8#?H?HG4>G[?ZB[1))3SK_`*A?5W_F]=]7
ML>I^+B9)8Z^RIP]9[JW-M:]]US;MWNK_`'?^+]-:70.B8O0>DT=)PWV68^-O
MV.M(+SO>^]VYU;:F?3M_<6@DDIH==Z-B]=Z5?TK+?971DAH>ZH@/&US;1M=8
MVQGTJ_W%@7?XM>D6]$Q^@_;<YG3\9[[/3994#8][M^Z\_9SO]/\`P7M77))*
M<W_F[T?]A_L#[,S]F>GZ/H=HG=OW?2];U/TWK_SOK_IOYQ5/JO\`5+$^K%-F
M/@Y>5?C6G=Z&0YCVM=W?5Z=-+F;_`,];J22G_]G_[1.:4&AO=&]S:&]P(#,N
M,``X0DE-!`0```````\<`5H``QLE1QP"```"CTX`.$))300E```````0(\JG
MKF9+%=Q!D:4?M-@)9CA"24T$.@``````Y0```!`````!```````+<')I;G1/
M=71P=70````%`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E````
M`$-L<FT````/<')I;G13:7AT965N0FET8F]O;``````+<')I;G1E<DYA;654
M15A4`````0``````#W!R:6YT4')O;V93971U<$]B:F,````,`%``<@!O`&\`
M9@`@`%,`90!T`'4`<```````"G!R;V]F4V5T=7`````!`````$)L=&YE;G5M
M````#&)U:6QT:6Y0<F]O9@````EP<F]O9D--64L`.$))300[``````(M````
M$`````$``````!)P<FEN=$]U='!U=$]P=&EO;G,````7`````$-P=&YB;V]L
M``````!#;&)R8F]O;```````4F=S36)O;VP``````$-R;D-B;V]L``````!#
M;G1#8F]O;```````3&)L<V)O;VP``````$YG='9B;V]L``````!%;6Q$8F]O
M;```````26YT<F)O;VP``````$)C:V=/8FIC`````0```````%)'0D,````#
M`````%)D("!D;W5B0&_@````````````1W)N(&1O=6)`;^````````````!"
M;"`@9&]U8D!OX````````````$)R9%15;G1&(U)L=````````````````$)L
M9"!5;G1&(U)L=````````````````%)S;'15;G1&(U!X;$!RP```````````
M"G9E8W1O<D1A=&%B;V]L`0````!09U!S96YU;0````!09U!S`````%!G4$,`
M````3&5F=%5N=$8C4FQT````````````````5&]P(%5N=$8C4FQT````````
M````````4V-L(%5N=$8C4')C0%D````````````08W)O<%=H96Y0<FEN=&EN
M9V)O;VP`````#F-R;W!296-T0F]T=&]M;&]N9P`````````,8W)O<%)E8W1,
M969T;&]N9P`````````-8W)O<%)E8W12:6=H=&QO;F<`````````"V-R;W!2
M96-T5&]P;&]N9P``````.$))30/M```````0`2P````!``(!+`````$``CA"
M24T$)@``````#@`````````````_@```.$))300-```````$````>#A"24T$
M&0``````!````!XX0DE-`_,```````D```````````$`.$))32<0```````*
M``$``````````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8`
M`0"AF9H`!@```````0`R`````0!:````!@```````0`U`````0`M````!@``
M`````3A"24T#^```````<```_____________________________P/H````
M`/____________________________\#Z`````#_____________________
M________`^@`````_____________________________P/H```X0DE-!`@`
M`````!`````!```"0````D``````.$))300>```````$`````#A"24T$&@``
M```#5P````8``````````````$4```&W````$0`V`#(`,P`V`#4`-`!?`$@`
M80!R`&0`8P!O`'``60`M`#$````!``````````````````````````$`````
M`````````;<```!%``````````````````````$`````````````````````
M````$`````$```````!N=6QL`````@````9B;W5N9'-/8FIC`````0``````
M`%)C=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````
M0G1O;6QO;F<```!%`````%)G:'1L;VYG```!MP````9S;&EC97-6;$QS````
M`4]B:F,````!```````%<VQI8V4````2````!W-L:6-E241L;VYG````````
M``=G<F]U<$E$;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG
M:6X````-875T;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E
M`````$EM9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4
M;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````10``
M``!29VAT;&]N9P```;<````#=7)L5$585`````$```````!N=6QL5$585```
M``$```````!-<V=E5$585`````$```````9A;'1486=415A4`````0``````
M#F-E;&Q497AT27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````
M"6AO<GI!;&EG;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0`
M```)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L
M=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````
M3F]N90````ET;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P``
M```````,8F]T=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG
M```````X0DE-!"@```````P````"/_`````````X0DE-!!0```````0````"
M.$))300,``````J9`````0```*`````9```!X```+N````I]`!@``?_8_^T`
M#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*
M"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``9`*`#`2(``A$!`Q$!
M_]T`!``*_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!
M`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#
M!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#
M)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($
M05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$
MDU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#O^OYEV/3775U"CIK\APJJMMK-
M]CGN<VMK,;&#ZMSMSV^_]/\`RZOSUYI]8>F]<Z7U#_*MS[K;9=5E[W.;8!SZ
M;W;75/K_`-#_`(/_``7Z)4<K)SCU&S*R+'6YU5I)?827;ZGR&:_18RQG\VWV
M,7J'6ZL3ZR?56R['AX?3]IQ':$MM8"]K>^Q^[?C7_P#7:U?C$\L874HSTD:^
M7_":$I#F8S`N,L>L1?YQ>=^I/UNR_ME?2.IVNOKO);BY%AE[7_2]"VQ_NMKM
M_P`"]WZ1EOZ+_"5^CV_4NI]/Z5AOS>HWLQL:L>ZQY_Z+6_2LL=^977^D>O%L
M2RQN3CVT3ZK;:GU1SN#VNK_Z2W_\>+\B.D,!(QB;W$`F#8/1V[Q]'<UCOT?_
M`%U1\[CC"8,17$-1XADY++*<"):\!JW?L_QN?5%KW"HY5];.;JZ3L^/Z1U=G
M_06[T'ZV_5_ZP[ATK+;=;6-UE#@YEC1I[O2M#'.8USFM]2O]&KG1Z.FXW2L6
MKI36MZ>*FG&]/Z)K<-[;)_/]3=ZCK/\`"+RAOV?$_P`<I'2/3;4RUWJ-KC8#
M]F+L]OM]OL?Z_JM_P=RJ-M[_`*M_C$^J/2<JS#RLX.R:CMMJI8^S:X:.8]];
M75;V.'Z2OU/48A=._P`9?U.ZCE5XE.:67W.#*FVUO8'./T6^HYGIM_ZX]>;_
M`.+7_G&RS-SNA]-QNHY#2QC[\IX:^L.%A(JW/K=^F_PJLY_[;^OWUJIZ'UIN
M+T;*Z=ZC7LAWJO;+'W,J)=:S)>UC/7Q_?75Z/JW_`*1B2GN+/\:_U-JL?59D
M7->QQ:YII?((.T_FJ/\`X[?U*_[DV_\`;+_[EH_XP?\`Q&=6_P"(_P"_-6/_
M`(G?_$?_`.A5OY*TE.YB_73H.7UJOH=-EASK6-M8TUN#=KZ6YS#ZGT6_J[U:
M^L'UBZ9]7<-F;U-[JZ++12TL:7G>YK[![6_R:GKS'./5Q_CARCT48[L\?S0R
M]WI1]E;ZF_T2VS^;W;%/_&;9]=W=!H'UAKZ>S$^UL],X9M]3U?3OV[O7>]GI
M>GZJ2GT3/^N/U=Z;TW%ZEG98HHSJVVXK2UQL>U[?5:6T5M?;]%WO=M].O\]8
M;?\`&[]4BX;OM5=3C`N=3[-/ZKG/_P"@N`H;BY'UXZ!1UF7].^Q].92RW6LL
M.)2^JO:[VNHLSW.]7_!_SN]>WY=>)9B6UYK:W8A8X7MM`]/9'O\`5W^ST]O[
MR2FMT[KO2.J=//4L'+KNPV[M]T[0S:-[_7]38ZC8SWN];9[%@Y'^-3ZDT6&L
M9SKBTD$UU6%L@QH\L:U_]:M>3]%LR*N@_6K[$]XP#10US^)W9=-=#7_\9C/R
MF_\`;BZ_ZA-^O>-]6\>SH&#TQV)D&QQOOWB^QS;+*B;]EM;?9L].K_@DE/5X
MW^,[ZI95>393?:YN'5Z]WZ)XAF^K'TT]WZ7(K1+O\8GU<HZ9C]6>Z_[!EO?7
M5>*7EOJ5F#4__1O?].K=_.;+/]&LKZV6_6*S_%UU=WUBJQZ,P/K%;<0N+#5Z
MF-L<[U'VN]3U/54/\7]/2K_\6OI=9%;NG.-_VGU3#`P6%V[=])CF.]];V?I&
M6?S7Z1)3UW_.#HW[&_;OVNO]E^GZOVF3MVSMV[8W^MZGZ'[/L]?U_P!!Z?K+
M.P/KY]7\_&^UT.O^SFQM+;74O`=8[\RO3W^E[?5V_P"EJ_TB\4<*Q-7J9S_J
M:WJ&E@:`XNV]MWZO]M^R?^E/29_-KWGIN#]7\KI&&WI]--O3&,!PPT2P-_M>
M[<[_``_J>][]_KI*?__0M_7CZL96-U"SJF%2Z[$RW;KFUM+G5W.^F75MW/\`
M2R'?I-_^G]3_`()6.@8_U@^KW2LO-SG-QL"QCO2P+`7WV7V-V8PHKK_HUE]S
MJV>F[U;+/^XU7\\O053S?Z;T_P#XU_\`YYN5\^[[$>,0X=-_GX?T?\)H1]GW
MY<'%QZ[?)_6>(^IWU(SVY>/U+JM?H4XT64X[OYUSV@&FRU@_F:ZW?I-COTWJ
M,_25UKMNL]$Z9US!=@=4H&1CN(>&DD%KF_1LKL9MLK?_`%/S/T?\V]74Z@YK
MW?<_65MZ>'Y>'P;'*^W[?ZO:_5?S<7B\9C_XK^GXE+L;#ZSU?%QGDEV/3DM9
M69^E[&T[5H_5_P"H?U>^K]5S<"M[LC(8:K,NUP?=L=^:P[6U5_\`6ZO?_A%T
M22KL[@_53ZF],^JM>37T^V^T998ZS[0YCH+-P;L]*JG_`$B%]8OJ'T;ZP9^/
MU*^S(P\[&`#,C#>VMYVD/I<YSZ[??0[^:LKV/_\``UT:22FAU3H]/5>CV])S
M+;'59%8KMN;L;88CW_S?HM>_;_H=G\A`^K7U;P?JUTW]FX-EME/J.MW7EKG2
M[:#K6RINWV_N+6224\_7]2>E5_6IWUJ%N1]O=,U%S/1UK^R_0]+U?YO_`(;Z
M:L?6CZK]/^M'3Z\#J%EU5-5S;VNH+6NW-;95!-M=S=FVYWYJV$DE/-]4_P`7
M_P!7.J]-Q,#,J>78%#,7&S&N#;Q76&L9N>UOI6_1_P`)3Z?OL].MBS[?\5W3
M[\4861UGJ]V$T`-QGY+75@-^A^B=1Z?M_J+M$DE/.O\`J%]7?^;UWU>QZGXN
M)DECK[*G#UGNK<VUKWW7-NW>ZO\`=_XOTUI=`Z)B]!Z31TG#?99CXV_8ZT@O
M.][[W;G5MJ9].W]Q:"22FAUWHV+UWI5_2LM]E=&2&A[JB`\;7-M&UUC;&?2K
M_<6!=_BUZ1;T3'Z#]MSF=/QGOL]-EE0-CWNW[KS]G._T_P#!>U=<DDIS?^;O
M1_V'^P/LS/V9Z?H^AVB=V_=]+UO4_3>O_.^O^F_G%4^J_P!4L3ZL4V8^#EY5
M^-:=WH9#F/:UW=]7ITTN9O\`SUNI)*?_V0`X0DE-!"$``````%4````!`0``
M``\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`#8````!`#A"24T$!@``````
M!P`(`````0$`_^$/9&AT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X
M<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC
M.60B/SX@/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX
M;7!T:STB061O8F4@6$U0($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+"`R,#$R
M+S`R+S`V+3$T.C4V.C(W("`@("`@("`B/B`\<F1F.E)$1B!X;6QN<SIR9&8]
M(FAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B
M/B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7`](FAT
M='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.G!D9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(@>&UL;G,Z9&,](FAT='`Z+R]P=7)L
M+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+VUM+R(@>&UL;G,Z<W1%=G0](FAT='`Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(@>&UL
M;G,Z<W12968](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]2
M97-O=7)C95)E9B,B('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P:&]T;W-H;W`O,2XP+R(@>&UP.D-R96%T941A=&4](C(P,3,M,3$M
M,#94,3DZ,S(Z,#DK,#4Z,S`B('AM<#I#<F5A=&]R5&]O;#TB36EC<F]S;V9T
MPJX@3V9F:6-E(%=O<F0@,C`P-R(@>&UP.DUO9&EF>41A=&4](C(P,3,M,3$M
M,#94,3DZ-#DZ-#@K,#4Z,S`B('AM<#I-971A9&%T841A=&4](C(P,3,M,3$M
M,#94,3DZ-#DZ-#@K,#4Z,S`B('!D9CI0<F]D=6-E<CTB36EC<F]S;V9TPJX@
M3V9F:6-E(%=O<F0@,C`P-R(@9&,Z9F]R;6%T/2)I;6%G92]J<&5G(B!X;7!-
M33I$;V-U;65N=$E$/2)U=6ED.C`Q,S9C8CDR+3DW9#$M-#(V82TY.3%E+3!F
M,V9E-V9E-V4X-R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HW,$-#,#)#
M0D4X-#9%,S$Q.#1!,C@Y,S`W.$(Q1$)%,2(@>&UP34TZ3W)I9VEN86Q$;V-U
M;65N=$E$/2)U=6ED.C`Q,S9C8CDR+3DW9#$M-#(V82TY.3%E+3!F,V9E-V9E
M-V4X-R(@<&AO=&]S:&]P.D-O;&]R36]D93TB,R(@<&AO=&]S:&]P.DE#0U!R
M;V9I;&4](G-21T(@245#-C$Y-C8M,BXQ(CX@/'AM<$U-.DAI<W1O<GD^(#QR
M9&8Z4V5Q/B`\<F1F.FQI('-T179T.F%C=&EO;CTB8V]N=F5R=&5D(B!S=$5V
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M86YC94E$/2)X;7`N:6ED.C<P0T,P,D-"13@T-D4S,3$X-$$R.#DS,#<X0C%$
M0D4Q(B!S=$5V=#IW:&5N/2(R,#$S+3$Q+3`V5#$Y.C0Y.C0X*S`U.C,P(B!S
M=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD
M;W=S*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ
M2&ES=&]R>3X@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240]
M(G5U:60Z9F4S-S!A,60M83<S.2TT-S)C+6)A-V,M86)E9&0P,6(P-F8P(B!S
M=%)E9CID;V-U;65N=$E$/2)U=6ED.C`Q,S9C8CDR+3DW9#$M-#(V82TY.3%E
M+3!F,V9E-V9E-V4X-R(@<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED
M.C`Q,S9C8CDR+3DW9#$M-#(V82TY.3%E+3!F,V9E-V9E-V4X-R(O/B`\+W)D
M9CI$97-C<FEP=&EO;CX@/"]R9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]0
M4D]&24Q%``$!```,2$QI;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``
M86-S<$U31E0`````245#('-21T(```````````````$``/;6``$`````TRU(
M4"`@````````````````````````````````````````````````````````
M```````18W!R=````5`````S9&5S8P```80```!L=W1P=````?`````48FMP
M=````@0````4<EA96@```A@````49UA96@```BP````48EA96@```D`````4
M9&UN9````E0```!P9&UD9````L0```"(=G5E9````TP```"&=FEE=P```]0`
M```D;'5M:0```_@````4;65A<P``!`P````D=&5C:```!#`````,<E120P``
M!#P```@,9U120P``!#P```@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````
M````$G-21T(@245#-C$Y-C8M,BXQ```````````````2<U)'0B!)14,V,3DV
M-BTR+C$`````````````````````````````````````````````````````
M`````````````%A96B````````#S40`!`````1;,6%E:(```````````````
M``````!865H@````````;Z(``#CU```#D%A96B````````!BF0``MX4``!C:
M6%E:(````````"2@```/A```ML]D97-C`````````!9)14,@:'1T<#HO+W=W
M=RYI96,N8V@``````````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````
M````````````````````````````````````````````````````````9&5S
M8P`````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="```````````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'
M0B!C;VQO=7(@<W!A8V4@+2!S4D="`````````````````````````````&1E
M<V,`````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V
M,3DV-BTR+C$``````````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ``````````````````````````````````!V
M:65W```````3I/X`%%\N`!#/%``#[<P`!!,+``-<G@````%865H@``````!,
M"58`4````%<?YVUE87,``````````0````````````````````````*/````
M`G-I9R``````0U)4(&-U<G8````````$``````4`"@`/`!0`&0`>`",`*``M
M`#(`-P`[`$``10!*`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`
MGP"D`*D`K@"R`+<`O`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3
M`1D!'P$E`2L!,@$X`3X!10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!
ML0&Y`<$!R0'1`=D!X0'I`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q
M`GH"A`*.`I@"H@*L`K8"P0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#
M9@-R`WX#B@.6`Z(#K@.Z`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^
M!(P$F@2H!+8$Q`33!.$$\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%
MU07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/
M!V$'=`>&!YD'K`>_!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)
M$`DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS
M"PL+(@LY"U$+:0N`"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-
M)@U`#5H-=`V.#:D-PPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z
M#Y8/LP_/#^P0"1`F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2
M)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P
M%1(5-!56%7@5FQ6]%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8
M&QA`&&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC
M&XH;LAO:'`(<*AQ2''L<HQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?
M$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=
M(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G
M&"=))WHGJR?<*`TH/RAQ**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI
M*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP
M-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43
M-4TUAS7"-?TV-S9R-JXVZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z
M=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B
M0"-`9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%
MWD8B1F=&JT;P1S5'>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB
M3"I,<DRZ30)-2DV33=Q.)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2
M?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:
M66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@
M5V"J8/QA3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6>3
M9^EH/VB6:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;QYO
M>&_1<"MPAG#@<3IQE7'P<DMRIG,!<UUSN'04='!TS'4H=85UX78^=IMV^'=6
M=[-X$7AN>,QY*GF)>>=Z1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C?X1_
MY8!'@*B!"H%K@<V",(*2@O2#5X.ZA!V$@(3CA4>%JX8.AG*&UX<[AY^(!(AI
MB,Z),XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1
MJ)(1DGJ2XY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5
MFT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:D
MQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZA
MKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y
M2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4
MQ%'$SL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/
M-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IV
MVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WF
MEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,
M\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_
M;?___^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!
M`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`10&W`P$1``(1`0,1`?_=``0`-__$
M`:(````&`@,!``````````````<(!@4$"0,*`@$`"P$```8#`0$!````````
M````!@4$`P<""`$)``H+$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`
M"#$403(C%0E10A9A)#,74G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S
M148W1V,H5597&K+"TN+R9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV
M=WAY>H6&AXB)BI25EI>8F9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:
MY.7FY^CIZO3U]O?X^?H1``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!
M40<R811Q"$*!(Y$54J%B%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D
M)PIS@Y-&=,+2XO)59756-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X
M=H:6IK;&UN;V9W>'EZ>WQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ
M.DI::GJ*FJJZRMKJ^O_:``P#`0`"$0,1`#\`W]R;"Y_WUS;W[KW4-YXW8^,F
M2\)8!+<@R!0P)L--_P`WM;VS*0H8UU-3^S!%6^=./RKP'6J58XTBA_4\A\O\
MO5./S=_G4_$/XA_Q?9F$SC?('NO'J\1ZSZORE#6XO#9$K^U#OO?@:?;NWO!*
MUYJ6)ZK(H%(--<>YAY#]CN:>>TCFN(&VS9AES*#J<'R130L*>8(%>!(ZA7GK
MWWY7Y&4V4%RNX[P:Z=!4HAH::W4G-:55030Y*\>M2/Y7?S7?F_\`+O/SU6ZN
MV,UU+L2*27^"]4=(9O,[-VU00.&6-LSFJ.JI=Q[RK%1[.U=/X2;Z(44A1F/R
M/[)<H<FQ1SR1I/<J!WR*KM@4Q44'V`=87<^^]G-G.=T=,TD-H"=*1LR*/3"G
M/VDD\*G'1#(-]=@PSI,O9'8T$R-J6JAW_O(U`8'5Y"[YMG,K/ZK@\'Z>Y1@V
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M7O?NO=?_T-^NMD98)/&L3RLNF"*9S''+,?\`-QR.%<I&S_4@$C\`GCW6+7(_
MPCP?7SZ;ED6-?^&>0]>JY/D?\+^Y_E]C<GM?L_Y>=F].];5ZSTM3UA\8:+%;
M(BRU)*B!8MZ=E[AI<UO;=$1T_N4U,,30.#9H''L;\L\U;7RM>"\M.7K6^O%9
M6#W)8M&P!&E%C=5"U);N#-7S``'4>\U<I[MS?;BTON8[O;[$J5,=J$TR`D'5
M(TJ,2PIITCLIFA+$]4]]L_\`"9/KY<'5M\??DQO';F>6-_X=A^V=K8'<FVLA
M41QF;Q3Y?:D6W<SC$GEOKJ/#5NHN-#"P,\V7WJ-S::WAWWE6S%FIIJA+HZCU
M4,Q5C_IB.H*W;[JVVM;RML?-%R]W(#_:A"&]`"BC3PH.V@\SUK?_`"J^%OR6
M^%6\:+9WR&ZZJ=MQYNJEI=G[ZP\YS76N^WAC\SP[6W73Q+3RY,4Q\IQ]2M/7
MHERT0`)]Y.\E^X?*?N!M^G8[H'<M(K'(:%2>`(X_LJ#Y$]8L<]>VW-7(5V4W
MJU<6%3^H@K4#S!^$_P"3HKK*RDJ18CZCBUB`1:S,+%2#]3[&WTDELBV]W:1"
MZ04?34BORK\J=1^L]B&9X)'H3@M\7Y^5:^F.NK@`C2"?I>Y!7F]P!P?=P+8A
M/#0"=34'S4^H^?3BW-\=:B]D^G84(Q1AZ'Y=/^TMX;NV#N[:_8&P]QY7:._=
MDYFCW#L_=N&JY:7+;?S=`S-25E',C#]LEBLT3:HJF)FCE5D)4H=RVNSWVVGL
M^885W"WDC9`LP%%U`K44IE:U'S`Z-MKWB?9+FWO-GA%O<QR*VI&8,Q4@@5KB
MI'EP\NOH<?RMOG_AOG]\=*3>]3%18?N;K^>GV;WAM*!?!!1[J%&L^-W;A*<2
M2,FTM^4$)K:(W(AE$],2S4[,W,?W4Y%NO;SF*3:(I'GVS!CE<`.RT&JH6BZU
M/$`4H5(`R!TZ]J>?;;W#V.+=7$46YH2+B)-5$8DZ=(8DT(&:L:,K"O`FS*$L
M5.O1<,1Z"2/H/Z_F_L`!44#0Q*G.>I-_4+/K`"U[?FOD3\^LWO?6^L;NR\*N
MIK"PN?J21S8'2/\`'W[KW0#=J_*CXT]$>6/N_P"0G2/4-5#`M1)1=C]I[)V;
M7B&2QBF3'Y_.4%;+'*IU`JA]//TO[]U[HG\W\ZC^4M3SST\_\Q?X?1RT\KPR
M*O>6R);21L5==29/0=)%KJ6'^/OW7NA`Z^_FJ_RU.U:YL7U[\]/B3N?(AQ$*
M*D[XZY@J9)GMHBAAKMP4KS.VH6":BQ-A[]U[H\V#SN)W+C*/.;?RF+SN"R4(
MJ<9FL+D:/*XO(TY8J)Z*NH)JFDJ8&939XY&7BWU]^Z]T[^_=>Z][]U[K@2VJ
MP%Q;_'ZF_P!3P`/]N??NO=`_N?Y#]!;)K?X9O3O+IS:.34NKX_<_9NR\!6JT
M9TNOVF6S5)4`HPLP*W!]^Z]TFO\`9O/BA_WD]\=__1U];?\`V2>_=>Z$#9O<
M74W8Y=>N>T.N>P'C#%H]E;XVSNAUTW+ZOX)E*[0%`-[_`$M[]U[I?F:1%!,>
MHGDZ21P20H(<!@?R?\`??NO=`15_*[XOXRKJ\;EODCT!C<KCJJHH,ECJWN3K
MRDK<?7T<ST]715E+/N))Z6KI9XV22-U5T<%2`1[]U[J/_LWGQ0_[R>^._P#Z
M.OK;_P"R3W[KW7O]F\^*'_>3WQW_`/1U];?_`&2>_=>Z]_LWGQ0_[R>^._\`
MZ.OK;_[)/?NO=>_V;SXH?]Y/?'?_`-'7UM_]DGOW7NE'M'Y!]']AYQ=M]>=S
M]0[]SSTT]:,%LSLG9^Z<Z*"F,25.0.'P>8KJYZ.EDG199`FB/6I+"_OW7ND_
M+\M?BQ32S4U7\F/CW355-/+3U--/W/US%/3SP.8IH)XGW('BGBE0JR,`5(L>
M1[]U[H1MC=H]==GT55E>M>P-B]AXG'Y`XO(Y/8N[,%N^@H,AX(JI,?65FWLA
MD*>DKS33)+XI&5_'(K6L??NO=+_W[KW3-E\]B=OX[)YG/9/&X/"X6DJ,CE\S
MF*ZFQN*Q6.I8FFJ:_)9&ME@I*&C@A1GDED94C126('/OW7N@-;Y>?%0I>'Y/
M?'5F-BH/=?6Y5E^IMIW)R;?3\>_=>Z&C:6[]J[\V_C]U[*W)M_=VV<LDLF,W
M#M;-XS<6"R"03R4L[4.9PU56XVL6"JA>)S%*X61&4FX(]^Z]TH)&*`$`L;@6
M`)//]`/?NO=`UVI\BNA>C8/N>Y^[NH.I8A3O5ZNRNR-H[(,E,BZC/!'N++4$
MLZ!0>$5K_@^_=>Z);6?SI/Y35#534=3_`#%?A]'44TGBJ$/>>R'\<@-BJM%D
MY(W(_-FX_/OW7NE;LG^;7_+"[%RL>%V7_,`^(F=RDKB.&A@[YZZIIY9&!943
M[_/TJ,[!38`DD_3W[KW1Y]L[OVUO7$4>XMF;AV_O#;N0)^RW!M;-8W/X6K",
M!(]-D\555='4*M['0[6(Y]^Z]TIO?NO=>]^Z]UQ8D6L+W-O];@F_^W'OW7N@
MQW;W9T[L"66FWWVSUALJJ@L9Z?=V_MK;;EA#'2/+%F,K221DMP+@`GW[KW2'
M_P!F\^*'_>3WQW_]'7UM_P#9)[]U[KW^S>?%#_O)[X[_`/HZ^MO_`+)/?NO=
M*;9WR"Z.[%S:[;Z][FZCW]N!J2HKUP.R^RMF[HS;T5(Z)4UB8G"9FNKC2T_E
M4R2>,HEQJ87'OW7NDTWRW^+$$L]/5?)GX\P5%//-3SPR=T=<Q2PST\C0SPRQ
M/N3R12PS(RNK`,K`@BX]^Z]TJ,/W[TEN7;^YMV[6[BZFW-M79<'W6\]SX'L;
M:&5VYLZD\$M4*K=>;H,Q48W;],U)3R.)*J6)2J,WT!M[KW237Y>_%(L;_)_X
MZ%"JLI7NOK>_/()_W\I!5E-P?][]^Z]T(VQNVNLNT(<E5]8]C=?]CT>(GIZ7
M*U6P=XX#>,.*JJN)YJ6#*2[>K\A'02U4<3M&LI5G"DB_OW7NA%]^Z]U'DED6
M0JJH0(]=F+*6-R"`UM"@#F]_Z\?GW[KW0`'Y=?%%693\G?CP&1F1E/=?6X96
M1BK*P.Y+JRL""/J#[]U[I4[.[^Z.['R5=A>N.Y>INP,SC<:V9R6)V5V-M'=6
M2QN(29:=LOD:'`Y:OJJ'$K.PC-3*JPB0A2US[]U[KK:W?G2>^*/=&1V5W)U+
MO#';'H:G([WR&UNQ]G[@HMG4=)!45%16;JJ<3FJN';]'!%1S.\E6T4:1PNS,
M`IM[KW7_T=\+>F^=F=?[7RF]M^[HVYLO:.WZ>2NS6ZMUYG'8#;^&I8+LU1D,
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MH222:Y/2?[NG.?,O.MYS5=[W=L;I8U*JQ-15VH3G&%`\L>76PUWOT-U9\DNL
M-R]-]S[)Q._.O-WT4E)EL-DXU#TDX4FCS&&K4TUF'SN-G/DI*RF>.>FE`96^
MH]XY<O[ON?+>Z1;IL]X\%Q&U5(/[01YJ?-3_`(:=9+;[LFV<Q[7/MF\VBS0.
M,@C(/\2GBK#R(^PU!(/SPOYA_P`$-^?R^_D+7]59ZHR&XNM]U)7[EZ3[&K("
M!O#:$=4JU.,S4D2BF3>NT6J(Z?)Q+I\^J*J15CET^^COM%[@Q<_;9:&2\5][
M$?\`C"9U*X)%37!5@`RD'AQH01US.]Y/;23D7?-Q:.R>+97E_P`78T(9"JTH
M1P()*D$8((].B)MQQ]+<6_I;_'W*9BCBO)PKU?3D>F>HEAS:Q-3!/'KC_M_]
MA]?]A?B_]/;IK0T'=Y?;Y=7!H0WH0?V=6I_R;?E96_%?YS];?Q+)?:=;]\RT
MW1W9M)<BC1MR5I.PMRL0C,)MN;P,">50--+7U"\`^X6]_N3+;F7D-+RQMS+S
M+;$RO&OQQA0=>JM!0K6M"3PH*@=3G["<\_U5YUEM[ZZ2+8MTJLCM4*I-:9`J
M&U$"N`,DFA/7T-*,*L;JJE=,KJ06U790H)!))L;<7Y/OG"ACTA(Y-07!^1\P
M?GGKI2K.1H:,JB=JU_$HX-^>?V=!UW1V[UQT-U1V%W1VWO#';"ZRZOVGF-[[
MYW=E)6CH\'MO`4DE=D:IEC62IJ:EXXO'!3P))4U-0Z0Q(\DB(;=6Z^7'_-7_
M`.%0/S5^:NZMS=>_&+>&Z_B)\5C)6XG!8?8^5;$]V=A89)9X8MP]E=BXF1<S
M@7SM.X<X7!5-+1TL1\$LM<5^X?W7NJ'?CQ\5_EI\\NV:K8GQUZF[0^1_9E8I
MRN;&#@K,W/0T<[R@9O>N[\Q518;;5!43(RBLRU=30/+Z`Y<@'W7NK]=K?\(_
M/YP&X\4,EF,;\8=AUCHLO\`W3W945F4C8J28'GV/L_=^$$BFRG16%">0WOW7
MNB6_+K_A.=_-G^&>S\MV'V!\:Y.Q^N\#35U=G-Z=";EQ7;%)@Z"A6%ZG*YK;
MF$:'?V-PU/#*TDE7+B$IH8XW>5T52??NO=$`^)GS_P#FA\'=UX_>?Q>^1W9W
M45325,%5+@<-N2LK=@[@$,J$T>Z>NLLV1V5N:BD$6@I74$P47TE3R/=>Z^F=
M_(0_GY[5_FQ[9R?3/<5!M_JWYJ=9X%,_N7;6`EJ:;97<VR*0TE!D.Q.M:6OJ
MZJMP^0Q>0J($S>#DFG:C$\552RRP23)1^Z]U9%_-F_F?=/?RI?B;G_D5V30R
M[PW5D\HFR>F>J,?DDQ66[/[*K:6JK*+#G(M#5-A=LX>CHY:[,Y+PR_:44)6.
M.:IEIJ>;W7NOE>_.C^=W_,E^?^X\U7]L_([>VT^N\I75<N*Z/Z<S66ZUZFP.
M/D#+3X5\-M^NI\AO%:2E;2U3G*K)53FY,GX'NO=%F^,7\N?Y[_.+[[.?&3XM
M]U=XXB"JJ(,AO7![:K$V6N1IV5:FAJ>PMQ2XS:#92!G7R4YR!J%#`LMB+^Z]
MT>/*?\)O/YUF*HJ2LD^!^^ZQ*VE:L\&+WYT]DJVB1#S3UE)2]B231U;"]HPK
M,?P/I[]U[JMON[XW_+CX-=DT.U.^NJ>YOC/V(47+X6/=&(W#L7)9"CI9HK9C
M:F<B^UI<[1T<\R@56.J)XHY2`7#<>_=>ZV7OY"W_``HU^4_1OR1Z:^*_S"[=
MW#WU\5^VMX8'K&DW9VCDJO</8_1VX]VUU)A=H[GQV_LF]1N'-[#ILY/!3Y?'
M9.>ICHZ"1ZJC>)H&@J?=>Z*_\I_^$X'\Y'?GR?\`DAO?9_PZR&5VCO#OON#=
M&ULM3=H]-0TN5VYN#L+<.7P>2I(JO?\`2U<=-78RLBD198HI`K`,BFX'NO=`
M5'_PF5_G9AP#\*LHVH@#7VOTD%O<?J;_`$C>D?XW`'Y]^Z]U33WATOV1\=.W
M>PNC.X=M/L_M'JO<^2V9OS:\E;C\D^#W)AYO!D<<U?B*NNQE88)!;R4\TD3?
M56(Y]^Z]T8#X8_R^_EC_`##-Z;PZZ^(/54O;6\MA[43?&Z<12[EVEMAL=MJ3
M,T&`7("IW?F\#05.K*9.&,0PRO+9M6D@,1[KW5B?_0,I_.T_[PLRW_HUNDO_
M`+8WOW7NK_/^$VG\F/\`F1_!/^971]X_*;XUUO6'5J=!]K;0.[9][];[BIX]
MR9ZJVF<10&AVON[-Y5:BO2AGL_@$01&U,.`WNO=:-G>$4</=/;\,,:10Q=H[
M_BBBC54CCCCW9ED2.-%`5$10``!8`>_=>Z^C'_PB94?[(5\L&L-1^7Q4M8:B
M%Z;ZTL"?J0-9M_KGW[KW6Z)[]U[JO+^;9!#4?RO?Y@\$\4<T,WP\^0<<T4B*
M\<J/UEN,.DB,"KJPX(/!]^Z]U\14"]_\%)]^Z]U]?W_A.9N;:NP/Y$/Q`WCN
MW,8G:FT-I==]V[OW7N#+5$&-PV!V_A.YNULWN+<&7K93'!28_'4,4M34SN0J
M(K,Q^OOW7NM/C^;M_P`*I/E!\H=Z[PZ>^`V\=R_&;XRX?)9/"4/8>W)9<1WS
MW;21&HH'W)4[D:%<EU3M;*0WGHL;BVILJD91JNJ+R-2T_NO=:S74O3'R<^;G
M<U!U[U+LGM3Y*=X[T-57KCL0,UO;=N0IX9@^2SV>RV1GJWQ^)HYJ@-59'(SP
M4=/Y-4TJZKGW7NK^=A?\)"OYP^\</!E,WMGXZ]8S5,$%2,'OSNN&JS4'G4-]
MO4#K_;>^<;#44ZM^XAJK`BW)'OW7NB[_`">_X3+_`,WSXN;2S6_<S\<\5W)M
M'!4E57YG*?'G>6+[,R>-QU#2S5577KL9(L3V%74\$,)9FI<3.4`)(`N1[KW5
M4?QT^8'RP^&>]*?>'QI[][:Z*W1BZH_=+LW=&7P^+JY89&2HHMS[/GDGV[N2
MD2?6LU%DZ*IIV8'5&?I[]U[KZ/G_``GZ_P"%&\'\R#+1_$GY:TFV=D?,;'X6
MLRVQ-V[<A7"[(^16&P%')6YZ*@P#2>#:O:&%QD$E=58ZF9J+(T44]51I3K3R
M4R>Z]U?G\_/G!U'_`"Z/BMV?\L^[JNNFVEUY00QX7:V*GACW'V+OG.3+0;-Z
M\VXU2?&,KN/,2!99&1XJ"D2>KFM3T\A'NO=?*8^?_P#/P_F2_P`P?=>>GW;W
MUN_I[J.KKZW^[O0'16X<OU]L3"X*26L-#CMRY'!5&,S_`&5D(J2I\<]7FJBJ
M6612T,%/&4B3W7NBE?&C^6__`#"_GE#6;I^-WQ@[O[UP=/4/25G8%%AZN#9)
MKXYWAJ,>.Q=X5>*VI5Y"FG5O-3I7O41\EE4<^_=>ZL<Q7_"6O^=EEJ%:T?$G
M%X[5*\7VN4[SZ.H*U=(!\CTTO8+L(6^BF][_`%]^Z]TX_P#0*S_.T_[Q7VU_
MZ/\`Z+_^S[W[KW5\7_"<K^1Q_,E_E_?S'J+Y`?*;HG#;!ZKBZ-[0V8VXJ3M3
MK#>-1#N/<S[;DQ%,F)VENG,Y;_*4QLRM)X1%&/U."0#[KW6B-W=%'#W-VY%#
M&D447:&_XHHXU"1QQQ[JRJI&B*`J(BBP`%@/?NO=;[7_``BCVOMK>'QT_F3[
M8W9MG![NVWNC>O2.WMS;:W%B<?FL)N7`9#9?:5)7X+.8K)P5%!E\174M9-'+
M35"/#*DKJRD,;^Z]U4Q_PHK_`.$_>6_EZ[QS7RZ^*>U\CE?@]OG-0'.[:IVJ
MLID_C)O//UA@@VWF'E>HK:KJ7.9&=(\%E99)'H:B5,96/Y/LYZ_W7NJ<OY6/
M\SGO3^53\F,#WYT[7MFML984>WNZ^FZ^OJZ7;/;_`%V*HS5&%RH034^/W-B?
M,]3@<JD3SXRM8DK+2S55-4>Z]U]@7X6_,OHCYZ_'K8'R;^.F\EW3UQO^@"-2
MS2PQ[CV5NNDB@DW%U[OC%1SU#X#>^UZFH$513,[I(ACJ('FI9H)I?=>ZT[/^
M%-W_``H.;:2;Y_EK?"'?31;GJ8:_:WRU[TVGD9/+MNEDC>CRW0O7F8I6!7<5
M="S0;KRD#C[&(MC(B:AZT4GNO=:,GQ1^*O>?S1[^Z_\`C7\=MC5F_>UNQ\JV
M-PF(B84V.QE'!$U3F-T;GRLBM2X':FV<9')69"NGM'3T\3'U.51O=>Z^F7T[
M_*$^,G\JCXD_&GH3=64H<CM7Y"?(O8.V/YC?R69'V[/V5BZK9^],EL7J'.;B
M@-)E-C?&/<G>5#M[;LE))6TM/+!7%*YGDRM6S>Z]U4#%A?F;L/XS;_[#[;QG
M9W5?S13X?]'_`.R<[*/7N`W%V%\AM[=Z[E[,QOR%GV3L3#=4;&QR[4VS\?L=
M-2;QZ?RN+W%!MZ?$XS<*SH*JC^X]U[K_TB9_-[YG=^?,;N+?N0[F[&W'N'9&
MWNQ-ZT/6_6:SMBM@[-P..SU9C,1!#M2@\.-K\RN.H4$U;6K454KKJ+BX`Z;^
MW/MQR?RSMUO<#:E%Z\2-J;+$E0:DG)R<#@/3KE9[C>XO.G,FZ7-I)NTC6:N0
M%![0M20`."@"G#YYZ)HOIX%@$70OU)T@675<V+*..`/]C[D>TEFDDW$RPE(D
MA(0<*KQZCJZMA#;64/BZY)9@S?)J4I^?'K8I_P"$UW95!M?Y==R]89&<P2=L
M])TV8P$3.JPU&6ZUW/#5U%-`K,'DFDPFYJB<:01HIGN1IM[QE^\[M;3<C<G[
MJJU$-PP/R$BT./\`3*O\^LJ/NL[O':<Y<R[*?CG@-/\`FV0W\@7QCUZW9O>#
M?6>'58'\V7X8X_YL?$/L#9N.HJ>;MCKNFK>T.DLD(D-?3[XVOCI:B7;T<V@S
M''[WQ2SXNIB!$;-+%(WJB4B1?:KG>?D;G3;9Q.5M[E@D@\BA(`;CQ0YK_"6]
M>HK]WN2;;G?DW<8S&#<6J,Z'T(6KBIX:EIZG4JTID]?.ICD\L:.T4L$I6TU/
M,A2:FF7TST\ZFQ2:"8,C*0"&0_T]]0W>*58;A/C=`3^?7+(6\UK)/;R'M1R/
MV>>?49ZY^ZCB/MZL>!ZZER=;A5_CN-FDILG@I*?.XVH@9DJ*?(X2IBRM#/3.
MI#)/#54:LI'-Q[+KN!;Y=[#?"8F_XZ>EEC*]I>;'H-'\51GAD@9^6>OJ>]%;
MW_TF=)]0]D$QM)V!UCL+>DQC(9/N-S;4Q.8G4,`H.B6K(^@^GODUN]D-OW?=
MK01Z-%S(*>E&(_P#KK[L%V+[8MFNA)JUVL9KZG2*_G6M?GUJ0?\`"T'Y.[AZ
MU^$/Q^^-6V\K_#Z?Y*]S9/.;]IH)I8:S,;%Z5QF.S$&&G2-T1L96;XW+B*U]
M:L#+C8[#Z^R_HVZ^:,P-2X,43ER8XUC0%R[$JB!%4?6Y"A0#]1[]U[K[2G\F
M[^7?UG_+C^"'2'3^SL#C*+L7<NS]J]C?(3><%&J9OL/N#<F"I,EN*HRN1;_*
MY\+M6>L;$X:F8B.EQM)'Z/-)/))[KW5K7OW7NH\L1L[I(T9MJ)7FQ4ZC92='
M(O<6Y/U]^Z]U\IS_`(5@_`/K7X8?S!MO]C]+;;QFRNL_EUL*J[9J-EX/&QXO
M;^V.U<'FY=O=FP[?HZ=C24>.W%+-C\W+3Q".*"NR=0L<<</B0>Z]U33_`"PO
MDUN+X>?/SXC_`"(VYD9:`[![PV0FZ5CFFITR'7NZ<O#M'L3!U)@=&EILYL?-
MY"G8'4JEP2#8>_=>ZV4_^%KG>&5W+\U_B]\?HLG5';/4_P`>*OL%\,*B04:;
ML[8WSF\=7Y%J19#"U0^W^O,=&DC+K4!P#9C?W7NM<;^5/\:NI/ES\]_CAT3W
M_OG;W7716XMZSYWM_=.YMY8C8.-CZ^V5A<ENW<&`CW7FZRAH\+D-Y08<8BGF
M659DFK5:.[JOOW7NOK_==?*/^7)U!LO:W6O5WR@^&?7_`%UL7"4.V=G;%VEW
MGTK@=L;9P6+B\%'BL3B*#=,-)24\(%S9=;.26))/OW7NE1EOY@/P/Q-%/DLI
M\U?B;1X^E354SR_(CJ0HBLP"Z@N[68`M^0+BW^O[]U[K14_X5L?S0O@_\QNO
MOCG\;_B]VUMOOO?/5W9^X^S]\=@;`*YS8&TL-6;/K-KTVS<?OA8%QVX<QN+(
MU<=7/%BYZFFIHZ!!42>4QHONO=:?GQ'ZTWGW+\H/CUU1UWAJW/[X[![JZQVM
MMG%T$<DM1/E,IO'$0QR/XU8P4=)&6GJ)C9((8FD<JBL1[KW7W;A]/Z_C_;<'
M_>??NO==']2_['_>O?NO=?%=_GC?]O>_YBG_`(M5VE_[NW]^Z]U?O_PB5_[+
MJ^77_BIT'_OX=@^_=>Z^E;[]U[KWOW7NO@M]Z_\`,[NX_P#Q*G87_O6Y?W[K
MW6[%_P`)5OYIO\O_`.!7PY^177_RZ^2FUNE-Z;P^2YWIMK;^>V]OO+U>6VLW
M6&P\''FJ:3:>U=P4_P!LV7Q%5`59TD1H;D:64GW7NMHC_H(^_DF_]Y\==_\`
MH"=U?_:R]^Z]T3/^8M_/Q_E"=S?`CYE]3=:_-G8>Z^P>R/C1W-LK9.V:+9O;
M-)5Y_=.Y=AYO$X+$4U1E>OZ#'PS5V2JHXP\TT<:ZKE@`??NO=?*/7^U_P4^_
M=>ZWD_D;\GLYT)_PCO\`A=USM3*U&(SWRFWOG.F,G44<KT]4^P*/N+N7L+?%
M&DZ$/X,S#LZDQE5&/3/15\R-P2#[KW6C?"VAP_/I!;@@>I1J3Z@@CR`<?GW[
MKW7U^/\`A.?_`"Y^N?@Y_+>Z/W9#M3&T_?GRBV!M3O+O#?%120/N7))OO'Q[
MIV)L0Y%%6KHMM;$VCEZ6G7'JY@.2>LJ"-=0X]^Z]U?T+@`$W(`N;6N?R;#@7
M]^Z]UAD@$DB2W`>-2$:QNMV5C9@P-F"V(_(]^Z]U\T?_`(6+_P`O[KKX[_);
MI7YC=2[:QVU,7\M:'>N&[=PN%I*;'X>H[EZ]_@=8V^HZ"EABIZ?+;_VUNA3D
M"H`J:W&2U;:IZF=V]U[K4U^-?>.\/C-W]TU\A>O\A58O>72W9NRNR<#5TLSP
MLU3M3/T65DH)Q&Z&>ARU/`U+4PDZ)Z::2-P4=A[]U[K=M_X6?_*F?>FR/Y=?
M2FU*V>/8_8FV=Z?*;,XYYI57(29'%;:VSUG4542,(9I,?CLYN`+=;JT_!%S[
M]U[K3#^%76G4/<7RR^/?6/R`['V_U%T7O#M7:&,[@[(W/EX-OXC:G6T>5@K=
MY5LF<J7CI\365.!I9Z:DGD942KGCU$"_OW7NOKJ]>?S:/Y*'4FQ-H]7]8?.[
MX5[!ZZV%@<=M?9FS-K=J[+Q.WMN[?Q,$=-C\7CL;3UBT\4%/%&#>VMG)9BS$
MD^Z]TO/^'M?Y1O\`WL8^(W_HY]I?_5OOW7NG+"_SG/Y4FY,UAMM[>_F"_%+,
M[@W%E<?@\%B,=V_M>JKLKF,M608_&8VCIX:IY)JNNK:E(HT`NSL`/?NO=6:C
M_;?X?T]^Z]U\%KO+_F=7<'_B4^PO_>LROOW7NM_G_A#S_P`R6_F#?^)0Z$_]
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M=O\`;6ZJ?;>SMK8B-JW*Y_/9&1Y)JBIK*F9(:2BI$$E7D*^JDBI:&CBFJ:B1
M(HW<>Z]U]<;^1_\`R7NKOY2_0@@JSA=\?+'M;%8RJ^0?<$=*E4BS11QUL'5?
M6U75TE/68WK+;5;(2[%8Y\W7Q?>52J$I*:B]U[JZ+=^Q]J]@;6W!L??6W-O;
MRV7NO%5N$W/M+=.%H,_MS<.(R,;0U^+SF'RD550Y7&U<+LLD,R.K`^_=>Z*[
ML;^7I\-^N#NQMI]%[;@FWKLS<77><R&;R^\-WYFFV%NW&28;<NS-JYO=^X\Y
ME=B;7SF+D$%50X2;'T\J)'=;Q1E?=>Z__].J[NG;-?L?N[NC9.5#G*;0[?[1
MVSD?("EJS$[RRJ3,B`6(D5U+$\@D>^M?+VXV^];;M^Y6T@>R%O'0CA\"]<?.
M9;:\VS=K^U8&.Y,Q!]<'3_.E?L/0;DG_`%A_3_C?LY$L\QE:60LA&E:^2'BN
M/*O1)I""(4_47)/GJ]?MZ,A\/OD;E?B5\G^E?D50)4S0=:[PII]RT%/.R39'
MK_.HV"W]BH&17)^_VO73LL=B#+&G`/L'\^\I1\[\H[CRSX*-.86^F+#$4HHR
MLN13(S4\*]#KVXYLFY.YTVGF`2N(_&43!30R(:@J?6H)`QQ/7TUMM;MPN\<!
M@MV;7R5/F]L[GP^&W#M[-T,HFH,O@\_119+%9*CF4:9::KHIT=6!Y#>^5<D5
MS%N.Y[5=P&*XMVTGUU`D$?D13KJH+N&6PVS=+28R6]SI*\/A8`@_+!'3XL<3
MO',44M:0ECR;,-+#^A#`<CVALXQ-%%<W(U7$9.ECQ4?+I;*&24VR&D+Y9?)C
M\P>OFW_S/^CZ/X[_`#[^3W6V*H(\=MVI["?L;:5)`ACIJ3;?:&-I-XT^/I5)
MXIL?D,A4PH!POCTCZ6]]0_9C?;CF'VYV:^O[EI]Q4F-I'H6*I50N/($8\_4]
M<M_>K8X.7_<7>K&Q@6';3W)&M=(X=PKZJ0.-*<,=$,]RB.(^WJ*CP/43*.(\
M9DI#PJ4%6Y!Y]"02,Q/]-*@F_O4>B']]57_0F_P'JT:R23;.K$F0R**_:PI_
MFZ^G'\`\76X;X0_$W'9"-HJN#X^=4M)&[%F1*G9N)JH`2WJ_X#S+P?I]/?)[
MG"1)>:=_D1JJ;J3/^VH?V''777DF&2#E+E^*4$.+9?V'(_D1UIP_\+A-D96;
M9O\`+X[%C"RX;';G[]V362>-C)#E<UC.M<]C(VE`T*M128*KTK?4WA)_!]AO
MH4]?/[P.0_@>8Q>7>(S?PG+8S)/1L3"U2M#6P57A6;0[0F3Q:2UN+_GZ>_=>
MZ^\ETUO?`=E=0=4]C;6K(:_;._\`K?8V]-N5T$Z5$-9@]U;9QF<Q%3#.A*SQ
MU%!6HRN.&!O[]U[H2O?NO=<218BZ_0@@D6_UC_AS[]U[KYS'_"W;L7;V4^0G
MP6ZJHZNEGW/LSIWM7?.?I8ZF.:JH,7V'O';>'VZ*F-'+PBKGZ\R#)J`UJ@(N
M/?NO=:9716V,QO+NGIK:>WZ::JSN[.V.O=L86DA5S-69?.[NQ&-QL$)169I9
M:RI1%`!.H\>_=>ZV4O\`A8HFC^;M0@M<#XG=*6+<NX7</927=N=;D@DDVX]^
MZ]UK\?#OX?=\_._O3:_QH^-.UL;O3M[>5#N3*8';^3W'@=ITM10[3P59N/.3
M29W<U;C<-2?:XC'S2@23JSZ++<D`^Z]U<<G_``E._G9*]W^,FS70:B5_V8'I
M$:@`2%#+O@D%K6!M:_\`3W[KW56?SO\`Y<7R_P#Y;G8>U>M/EUU)4]9Y_?.V
M3NS9M929W!;QVQN?$P5(H,DN&W9M;(97`UF4PE:R)7T2S_=T7W$#2QJD\#2>
MZ]T%OQ4Z9V;\B._>J^C=\=W[*^.N`[+W#3[5F[@[%H\K7[%V?D\FKIB)-SP8
MD)-1T&2RJP49K97CI*1YEFJI884DE3W7NOJ>_P`H3_A.E\4/Y5><I^Z9]PY3
MY'?*Q\748VE[DW9A*/;NWNOJ/+T`H<Y0]3;$I:O+Q[<FS5++-35&6JZVORDM
M'*\,,E-!-412>Z]UL00`B&,'7?0/UJ$?_D)5X4_X?CW[KW60_J7_`&/^]>_=
M>Z^*[_/&_P"WO?\`,4_\6J[2_P#=V_OW7NK]_P#A$K_V75\NO_%3H/\`W\.P
M??NO=?2M]^Z]U[W[KW7P6^]?^9W=Q_\`B5.PO_>MR_OW7NKFOY4?\@'Y+?S=
M.E.QNZND>X^C^N,)UGV>O5>4P_:,^^$RV0RT>U,#NN3*4/\`=;:>XJ6+&"AW
M%!$-;+)),K^G2H/OW7NK1_\`H"?_`)@G_>4?P^_\[.X?_M6>_=>Z!GY%_P#"
M0_YP_&GH#NSY";M^2'Q7SFU^D^K]Y]I;APVWJOM-\[E</L;`UVXLGC\,N3ZZ
MQV/_`(E/28]UB$TT49<@:A?W[KW6IDO]K_@I]^Z]UMY_/_96<S/_``E,_E`;
MXH:<2X78_P`A^Q,?G)A?73'=^X/D1%BY.`=,;U>'>,DV&IEYN0#[KW6H:JLQ
M.D7LK,?SP`;_`.\?[S[]U[K[C'\M;M#:_<?\O?X2]D[2KH*O![H^+G2,T#1R
MK)]OD,9UY@,-GL7(PM>JPF=Q]31SBP*30,"`1;W[KW1W??NO=<6=%(#.JD@D
M`L`2!]2`3<V]^Z]UHC_\+?NR=O0=3_`OIY:NEFW9ENP^X^RY*!95>NH=N;>V
MWM7;$-9-"I+0T>4R.YI$B9K"1J.0+?0UO=>Z^>334\]7-'2TT,E145$D4%/#
M"I>22>:5(HHT1;L[R.P50/J6`_/OW7NMN/\`X5QXG,;7[P_EM;0S2RTU?M7^
M71USB:^@<,@HLS0;OW/BLJ!&ZK)'+YL<J/<`_M@6!'OW7NM:+XC?&;L'YE?)
M'J+XN=4UFV,?V)W9NN#9FTZ[>60J<5M>ERD])5URRYK(46.RU7348@H7NT5-
M/)JL%0FWOW7NMD-_^$:G\UX,0N]?A\ZC@-_I7W\@/^LHZDOI_H38G\^_=>ZX
M_P#0&I_-@_Y[+X??^C:W_P#_`&I??NO="OT/_P`)#?YI?6/>/2O9&=W9\2JC
M!]?]N];;VSD&.[3WQ49&3"[5WEALYE!105/5=-#4U?V-#)XXFEB61P`76]Q[
MKW7TT0;@&Q%P#8BQ%Q>Q'X(]^Z]U\%OO+_F=7<'_`(E/L+_WK,K[]U[K?Y_X
M0\_\R6_F#?\`B4.A/_>4[)]^Z]UO5D@<D@#_`!_P]^Z]UJI?\*8/YSO1GPP^
M/.__`(4[8P>P.\_E#\B=A5VV<]UINS&T>[MC=1=8;JHWIZC?/:&':5:>7=.1
MIG\NUL1*1-YU3)SA:6*".M]U[KY8*4=3.MJ>EGF*1U,[&*&61S!2Q&:JG945
MM-/21(6=C8(MR;"_OW7NK2?Y/_\`,XWC_*@^7&`^2&!V1MSLG:.;Q%3UUVWL
MC)T6/7<N7ZUS.1QE;FI-A;FJ('K=F[RH9:&.HHZF-UIJHPFFJU>"5@/=>Z^P
M7\4_E5T5\R^D-@?(_P".N_<;V!U-V3BA683-TK>&NQF0@)CRNTMT8J0_=;:W
M;MJLU4M=CJ@)-!4(P((TLWNO=&7!!^A!_P!;W[KW7?OW7NO_U&O^>G\>:GHG
M^81V%NBDHI8-H?)##8CN;;E4`II9LZ*>';785$A1$C2>FW#CHZIXQZ]%<CO^
ML$]"ONY\T6^[>VUSM2@M>V[E*U!``RI]?A(_.O7.'[R/+IV'W%CW(Q4LIPKB
M@T_$<@>7Q!Q7A@=4]M]%_P!C_O?N?@FBUL5)!?P\_;7K'YI%EN+N1%(0O@'T
MIUT/KS>QNK6`)TN"K@`@@W1C[TLDD3"2%@LHX$\!Y?X.O:!)V&M#Z<<9'\^M
MK?\`D$?S,<7BJ#"_`/O'<0H9XJJ;_98MVYN>-*&MHIF>KK^E:RNGD409+'SM
M)4;=5K^>GDDHU8/%3QR83?>/]K)+.Z_KGRPH$<A!N8Z$DFN9%`'`CXLXH#3B
M1FY]W'W9%Y`.3.9)2TL9I;N2***4T-4UR<K04#:@:`@];90=I(@"A20H04X!
M!N;C@V!'O$D2>)^AX1C=TU9\O*AIY^>.LP$#(_B,PD9&TDKY_,?+/GZ=:,/_
M``HQVU'A_P"8#MK<"H%DWI\>=DUE0X=#YI-O[BW1AE?QKZXV6,A26_4`+?3W
MG[]V"5I.0;D%JJMXX\^-$)I\L_MKUSZ^]';K'[@+*!EK:(_M#+GY]G[*=4-^
M\D1Q'V]8T=+7K;K;.]S=D]==/;8H:G([B[6WOMO8&'HZ1&::6HW)DZ>@J)`%
M!TP4=`\U1,_TCAB=C]/91S%NEMLFW\P[I?/X=C'`[:R11J*30?,\!T(]CVB?
M?N8-FVW;OU+H2*"@!)!J*'`\C3AU]3+8VV\?LO9^V-EXF,Q8C9VW\'M3%(2#
M;&[>Q-%B:(<?2T%*!_L/?)"3<#N5WN-RT#1L;B3!\ZG54?+NH*YQUUTLK7Z+
M;]NM=88QVZ*2.%573_DZJM_G>_RVY?YG_P#+][-^/NVI,91]R[;R.-[<^/V4
MRM1%18^'MC9T&26AP.3R50C+CL3OG`Y;(826<D14C9!*EPP@TGW2CKXY'9W6
MG8/3>_MV]5=L;1S_`%]V1U_G\IM?>VR=UXRJQ.Y-L;AQDS4V1QV5QU:JRI4*
MX!5Q=)$*R(64J3[KW6X-_(@_X4^;?^$G3VT_AE\Z]L[UW9TAU\L]'TQW9L2C
MCW)O/K3;=3/-6G8>]MJ5%925>Y]C8FMFD_A590R-D<92,*/[6HITI_MO=>ZW
M%]I_\*$_Y,F\L'2Y_&_/WIC&4U5&D@HMV)O+9><@+(',55@=U[6P^7AD3Z&\
M.G5P"??NO=$;^8W_``K"_E5_'G:.>?I#?>X_E_VI'CZH;>V7U;M?<>W]G3Y;
MT1TD6ZNS=[X/"8?'8(M(7EFQ4.:G"H0M.Q*^_=>Z^9[\XOF?W+_,%^3G:/RI
M[WR%+5[^[+S$=4N+Q?W$.VMD[4Q--'C-J;"V?054]1+1;:VI@Z>*"$.[SSNC
MU%0\M3--*_NO=;#?_"5_^4SO_P"4ORWV1\YNS=J5N.^+?Q1W5_>?:>:RM*8:
M'MSO_"LTNR]M[2^^@,&6Q77.9:/-9>MA/BIJNEI*2Y>HD,/NO=)?_A8N#_P[
MQ1&PM_LI_2QO<&X_O%V6MR!RIU<6//Y^GOW7N@&_X2D_]OL_C9_X9'R`_P#?
M)[V]^Z]U]</W[KW5:?\`-8_EH=,_S3OBCNOX[=HQ4F#W32K4;IZ4[72@2KSG
M4?:%'130X?<=*0\4]9MW)"3[+-XT.B9#'2.`T=1'3SP^Z]U\;[Y3?%GNKX9]
M]]F_&[Y"[3GV;VMU3N"3"[EP\DCS460IY(XJW#[EVWE3%'#F]J[IP]5!7XVM
MC`6JHITD"J25'NO=;\G_``EI_GQ+W)@=K_RTOE_O=I>W=IXH8OXI=H;JKP:G
ML_9V&I0:?I3<66JY+U'8&S\9`QP$\K7R^(@-(Q%920_?^Z]UO$`W`-B+_@_4
M?Z_U]^Z]UT?U+_L?]Z]^Z]U\5W^>-_V][_F*?^+5=I?^[M_?NO=7[_\`")7_
M`++J^77_`(J=!_[^'8/OW7NOI6^_=>Z][]U[KX+?>O\`S.[N/_Q*G87_`+UN
M7]^Z]U]&'_A$U_V03\K_`/Q;]O\`WS?67OW7NMT/W[KW5>_\V?\`[=A?S`O_
M`!3_`.0/_OL]Q^_=>Z^(BO\`:_X*??NO=?48_EX?!+;G\R/_`(2R=)?$G-Y"
MEP&7W_UMV/D^N=V5D=1)3;1[6VCW_P!@[DZ\W!6I2D53XB/<&.BILDD8+S8N
MIJ(U]3CW[KW7S5OD#\<^Y?BIW%O_`*&[]V/F.M^V>LLW)@]S[1SD7BK$J`Q:
MDR.)J(R])F]OY6B*5=%D*226DK:26.:%WC=6/NO=;+?\@_\`X4>M_+9V:OQ(
M^5FU=U]E_$R7/9'/[`W5LH4N0['Z*R>?JEK]R8Z@P.1J:.@W?UOF\O))D&H8
MZBEK<=6S5,\/W/F\">Z]UO!;`_X42_R8>PMOTF>QOSRZKP$=1!!))B]_XW?.
MP=P4;RJI-/5XG=FU,34F>)C:0Q"2,$$AB.??NO=%C^5O_"IW^41\?MLY6JV#
MW+F?E/V!34E5_!M@]';2W))2Y&OBB,M+#E.Q=UX?;^R<5B9:C2):BGJZ^>);
MLE-*5*^_=>Z^;!_,Q_F-=W_S1/E7NKY*]W14V!K*W'46R^N.ML'6U%9M/JKK
MC$33SX+9N#J:P15-<XK:^JK\C7R)&U?DJR><10QM'!%[KW5BO_"=+^4GOO\`
MF&?-/8_9V\=KY.G^(/QIW=@>QNW=[5N-JDVUOK<>UJREW!M/I+;U;+$E)G<S
MNC,4M.^9@A<F@P*SR2M'-/1)4>Z]U8U_PMB;7\[_`(F.;7;X?HW!N/5W+V0>
M"0+CGW[KW5'G\@?_`+?)?R]O_$_XC_W19[W[KW7V>!]/]B?][/OW7NN_?NO=
M>]^Z]U[W[KW7P6N\O^9U=P?^)3["_P#>LROOW7NM_C_A#VP7I7^8.Q^B]G]"
ML?\`6&T^RB??NO=6K_S_`#^?AL;^5UL!^D.D9L'OSYV=C;=:NVEMRK2'+;=Z
M)VWE8YJ>A[3[(H3K@K,U/I=MN[?DN:Z9155:BB1(ZWW7NOEA;BW#W!\E^W\E
MN'<63WSW3WOW=OC[BOK9DR6\-^=D]B;RRW@I8(8X%JLGF,YGLK7+!3T\".SE
MEBB0#2OOW7NOJ`_R$/\`A/SUI\!N@\_OWY7;(VGV9\MOD9U]D-I]K8+<-%CM
MS[/ZCZEW?2A,QT3@X9?NL=E,GGJ*1!NO(J)(:J510TS&D@:>M]U[K3'_`.%`
MW\CK=?\`*K[VB[!ZHH\QN/X2=V[@K_\`1+NFI:IR=5U5NB<5&2J>D-]9-S+.
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M7U9*DIEX#%A*WL=STWMYS7%MMS/_`+K;JB2$_"*L=#D\.TL5;T4U-`.H4][>
M0[7W$Y1DW:WB(W"U1BH`[F5?C6E-6"H=17C44)8=:`\<@EC$MFC#,Z^*9?%-
M`T;M')3U4;6:*L@D4I*AMI=2/J#[Z7*P=$E#@HXJ""*?RQUS.EC:">:UDCTR
M1-I(.#\C]E.'J,^?64?4>ZR*7BD"^G'R'Y]>C<12(Y\CP_V.O%3>&1'G@GIJ
MF"LHZNEFEI:NBKJ.43TE;0UE.T=31UU'/&)(I8V5XW4$$$`^TL\-IN4/T5[`
M72E.%1_@].M6-[>[;?\`UEE-H<&O&AZV]/Y/7\Y;M'M_<FT/B#\B]G;Y[4WH
M:2DQVSN_-A[<K]TU<>*C7P0?[,)28R%TVWX:>.PW/J6"JLIJHUE9II,*_?'V
M9L^5[M^9-DG@BVR=#(82RKH/F(\X)-2(R!Q[:8'6=GLA[UWF]6D7+N]6LSWD
M+A5E"LVM:TR>+JN!K!JHP=5.JP/^%!6]:7=G\QC.X*BF2I3K+J#K/9M7(K:V
M3*Y*FRF\JRD-B1JIZ3/4S/Q?5)8_3W+WW9;4V_MG),^->XR`5Q4!%&*\<K7'
MKU#_`-Z&^2Y]R5MT<'191U`\C4G_`)_I3RT]4CLRJC.Q4(BEV9F"HJ@$ZF<D
M*BFWU)M[R%*FE&!4'S.!GSJ<=8Y`T9:9:HH/7Y#UZVGO^$]?\O\`S^1W&WSS
M[7P$F-V_BL=FMM?&?%Y>B,-1GZW+1?P_=7;BTU2FM,324'EQ>&D*VG:6JJ$8
MHL#MAK]Y3W,,FCVVVZ="T#5F=6J#0`A*J:&M0Q'I0>?6:OW:?:^2TO;GW#W:
M(B.0,L2L*'430M0BM%&H:@15F%,IUMWTZ:%87+7<L6))+$A022?];WB"'5A@
MY&#]O68R:B96/!F)'V>765T61&C=0R,+,I^C`_4'_`^]]7ZJ?_F,_P`E_P"`
M/\SF"'(_)+J-Z7M*@Q28K`]]=:9([*[>P]%31SI0T%7GH*6LQ6[\3C_,Q@H\
M]1Y.FI[L84C9B3[KW6J5W=_PB)W4N4J:KXU_.W!5&!EC_P`DP?>'560H,Q3D
MN]XJO=>Q,SD*6M4(%&M<-3EN?2!8>_=>Z)E6?\(KOYE"U4Z47R&^%M72I*WA
MJ9]W=S4DTZ'Z224R=*5:PE_]3Y&M_7W[KW2^V/\`\(G/F_DJB%.R/EW\7=F4
M&H>>7:&*[1W]5QJ7*EH:+*;5Z^@G<1`'U5$?UM>W/OW7NKJ?AI_PCM^`/1&<
MPV\_D[V+V5\P-PXJ6@K4V?DJ2'JKIYJZE1*F493;&W*_)[OW)2&I7TPSYU*2
M>,>.>FD5F4^Z]UMF;'V)LGKG:.W=B]>[1V]L39.T<338':NS]HX>AVYM?;>&
MHE*4F.P6"Q5/28S%T4"?I2&)%']/?NO=:G_\Y7_A-#V/_-7^:F2^5>W_`)<;
M.Z>Q=5UEL'KR#9.?ZGSV\*^EFV9#E!4UIS-!O7`TGV^0DR?E2,0`H2023S[]
MU[I'_P`I#_A+OV5_+)^=G5OS`SWS`V+VYBNOL#V-B*C8F'ZBW!M7(YAM\;#S
M^SXY(,Y6[YS-)1#&R9@5)U0/Y!#HL-6H>Z]UN0^_=>ZXE03<CFUOZ<?XV^OO
MW7NM?;^=[_(;ZL_F^8#8>ZL-O#$]#_)SK.>+!X7N=]K3;DHMS=654U3/D>O=
M\X.ARF$K,W38[*5#5V&JON5DQL[U**#%5S`^Z]UKL8#_`(1.=_[1SF%W3M?^
M9'L;;NY-MYC%Y_;VX,'T;O+&9K`Y["UL.1PV9P^4H>THJW&93&9"G2>"HA=)
M(945U8$`CW7NMZ[XR[=[]V1T?UOLWY,]D[2[C[IVS@:;";U[5V1M&MV3A>P:
MC'N]%2;KJMKUN1RBX3/92AACER4=/+]G)6O(]-'!"R0Q^Z]T/TQD&DQ@$@FX
M)T@_FU[&VJUKV/OW7NM&_P"=_P#PD/[6^9'S)^2GRGQ_S?Z]V+0=]=N[N[,H
M]G5W2FX\W6[;IMS9!JV'#U.6@[#QT&2GHD?0TR01+(1J"K>P]U[JPS^13_PG
MPW[_`"??D)W%W-NKY.;0[RQW:73@ZPIL#M[K7,[)K,36IO;;FZ_XQ45N2W7N
M&&IIE@P30>)41B\P:]EL?=>ZVBO?NO=<7;0I:U[?CZ7OP.3PO/Y/OW7NOGP;
MX_X10=P;VWOO/>*?S`>M:*/=>[=Q[CCI).@]TR2TJ9O,UN36GE?_`$E0!I(%
MJ0I(4*2+CCW[KW6RO_(L_E*;J_D_]`]O=';J[MV]WC5]F]T'M2#<&W=EY+9-
M-AZ4[(VOM,8:>AR>?W!)65+3;?,_E255"R!=-Q<^Z]U>5[]U[HL_S&Z.R'R>
M^*OR.^-^,W-2[,R?>O2_8W5..W778N;-46VZK?.ULEMV+.5>+IZFBER5/C6R
M`E:!9HFD"Z=:W!'NO=:)G_0#YW$ND'^83UGJ>Z@+\?\`=3#5:]KCLTD+?ZD@
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MV43P4-?L;94$K,K'T-4QB_Y]^Z]U;_\`$+_A&/\`"[JG,X+=/RU[Q[/^462Q
MQIZFKV'MO'0=,]75U;%4:VBS)QN4W!V!E\7(BA3'39C&N23K+)P?=>ZVZ^IN
MF>I^ANN]L=2=+==[0ZMZRV9CXL9M?8VQL%0;<VWAZ2(&_P!MC<9#!`:JHE)E
MGJ'#5%1.S2RN\C,Q]U[K6\_GJ?\`">S?O\WWY"]0]U;3^3NSNC,9U?TM'U3-
MMW<'6F:WO6Y:K7?&Z-UG,05^,W;@(J:D:#<4<'A:)W5H2Q8A[+[KW1$?Y>7_
M``DD[1^#WS8^.'RRR_S7V!V'B^B^Q:/>];LK&],[BV_7[B@I<=DJ/^'4F9J=
M_P"5IL?-(]:"'>"10%/!]^Z]UN\0EV0EUTDLQ`_HI-QS^?K]>/?NO=9??NO=
M>]^Z]UPD9E0LJZB"OIX!(U"X!/`)'OW7NOGO[T_X10]P;VWGO#>"_P`P'K.B
M&Z=U[CW$*,]";IF-)_&LQ69(4YF/94'E:%:D*6"`$CCCW[KW5Y/\I#^2?\EO
MY1?QO^9?6O4?RHZEWUW9\BZS860ZP[#W)T[N:#975N8VGB]R8:JSFXMGKO6K
MK-X2PTNY7J:*G6JIZ9JNEC6HUPNZ^_=>ZI.[._X1J_*CO'L3>O;W;'\S_:?8
M?9?8V?K]T[VWKNKHS=^2SNX\[DIS-55^0K*GLX$,;JL42!(H(52.)$B1%'NO
M=6V_R9/^$TW4G\KSMW._(WN;LC"_*;Y!45\5TWG(-A3;4V=T[AJREBI<[N;$
M8+*YG<=17]C94U$E)'D?,@Q^.+I`JO432#W7NMIB."*)BZ*`S#U-]2Q+,Q))
MYNS,2?\`$^_=>Z+]\I/C+TO\P^C>R/C?\@]GTF^>INU-O38+<N$J;Q5=*X(G
MQ>X-N9!4:?";KVYDX8J['5\'[]'5T\<B\K[]U[K10S?_``B![%;/YIMJ_P`P
M?946V7RN2.VUS_06X9\XN"-7,<7'G9Z'L6FQLF66@,8G:!$A>8,8U5;`>Z]U
M>C_)9_DO_-O^41N[<FV)OG9L+O'XK]B?Q#([NZ-J>IMU8*IP&^CCVAQ/8/6.
M8J]^9O'[7S]1+!#3Y>-Z9J/*T**)HS404LT/NO=;+]W^WO<^3PWU:3?7H^NB
M^J^K\?7W[KW7_];?I:-_U+8-I4@GZ:D>_/U_`]IVE66U2Y=.Y"2!_+^?3:+X
M=^TE/TG6A_9UJ-?SF?Y-NZ5W+NSY>_#O9E3N*DS\U=N7O/HG:]*DN:ILQ*6F
MRO9?6.%@7RY),HY\V8PU,C3F;74TRN7>-<O?9'WSM4V^TY4YKG*Q!U6&9^&B
ME`KL>!!P'.&P#D5.'?O?[$37-_>\Y<LPEBX:26-1E7KJ)4#BAR:`=F?(CK6!
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M_B__`"]>B=W9;8FQME])],=9[9S.\=[5^*HXH:RNH\)0RUDU5FLW6/-FMT9Z
MM>T43U=1//--*L278@>\3;W<N=O<?FS9K6XE>XO+V0!RYK1B:!0HH``/B-*Z
M:UP.LK[7;N4_;7E/<[RVMEAL[.$E0/B8``@%S5B7;`%=.L@T%>OG\C:GR3_F
M8?*GMS>?4W6>Z.SNQ>V>P<OOG+4.%I_'MC86*S56E-MVDW;N[(O#MW:V.V]@
M8::F!J:E2?"RI&[``])_WIR)[-\K[=L&\7\<EO;Q!XLU;QM/<0,DL1^$5I7K
MG')M'._O!S1N>];9M#23S24E8+VQQEA1@10!:U4-BH%<5IULJ_";_A.SUAL0
M8CL/YJ[EQW=&\(#35L?3>RY:_%=-X>K*(RTVX\E(*3/]ARPLY$D3+18TNI'A
MEC/O%+GO[Q?-O,4ES8[-<-;;4=2J2!K*Y&`<)4>M3G@.LI^0?NV<K\OQ1;AO
M<QW7<0%)CKV*V"<@DL!PQIJ/,C/6R]B,10X7'X[$XJ@H<9B,514N-QF+QM-!
M0XW%XZ@IXZ6@QV/H*:.*FHZ&CI8UCBCC54C10H``'O&IW2Z75^&OYD]9/6T)
MMHRFJIH/L`'`#[/]6>G:,D@W%O4;?ZWO85$`5.'5HF=@Q<9K_+KG[]TYU[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U_]??M_;T_P"[;:6_I>US_O-_I[I-H\'NIX51P_U</7IN/_<4
MTU:,\?B_U>G6/]C4O^=\ND:;:?+X]0TWMZO'K_KQ?VQ-X?C1:=6O1C1PI7SZ
MU;?V)KJ\/5^/U^5.BZ]>_P"RF?Z7^SO]%/\`H/\`]//EH/\`3%_H_P#[C?Z4
M_)=?MO[]?W?_`-_);7;R_<?V_P#.>KV(;O\`K']!:?7_`%O[LKV^)J\/Y<>W
M_2TZ)+/^JGU\G[O^@_>6?[/P_$K0UTZ>ZNFNKY5U=&.B\5QX_);2MK6T6_'T
MX]ALZ/J#_:Z_Y="3_0Q33IZI/_G`0=>2;3Z_J/F'D^Y:/X!4V_<+%VSB/C[@
MX,C6YG=TRAMH5WR)W$=PXK>VVNE<=EA$E-2[3Q>6GK<JT;U]12A:=&EOVL_>
MO[RW+^J0M3S+X3_[EU`IVU^EH"#)33\=!2OX=740^Z7[K^BV_P#K:;O^KGB=
MOT@6M:'_`'(UFE/CT4&JO#NT]6%_$#_90O\`0?MC_9+/]%W^@WQC^$_Z)?X?
M_!_OO&OW/]X?M/\`<G_>?]/W7\5_W(^7_.^OV%.:_P"L_P"]Y?ZU?4_O74:^
M)7_C/X=/"FC'0NY,_JM^[(OZG?3_`+MT"OAZ=7G_`&E>^O'XL\:=M>C.P?:^
M)M/ET:A?R6_7JXM_L?I^/8?F\32*5K_1X_/C_/H5P^!63Z/PZUSHZ<A:PM]+
M?[[_`&/MB/1X8T?#3JQZZ6UC:_U/U]M6VC0VC534?BXU_P`W7FXYZY>U/6NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
-=>Z][]U[KWOW7NO_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
